- •Contents
- •Preface
- •Contributors
- •1 Vessels
- •1.1 Aorta, Vena Cava, and Peripheral Vessels
- •Aorta, Arteries
- •Anomalies and Variant Positions
- •Dilatation
- •Stenosis
- •Wall Thickening
- •Intraluminal Mass
- •Perivascular Mass
- •Vena Cava, Veins
- •Anomalies
- •Dilatation
- •Intraluminal Mass
- •Compression, Infiltration
- •1.2 Portal Vein and Its Tributaries
- •Enlarged Lumen Diameter
- •Portal Hypertension
- •Intraluminal Mass
- •Thrombosis
- •Tumor
- •2 Liver
- •Enlarged Liver
- •Small Liver
- •Homogeneous Hypoechoic Texture
- •Homogeneous Hyperechoic Texture
- •Regionally Inhomogeneous Texture
- •Diffuse Inhomogeneous Texture
- •Anechoic Masses
- •Hypoechoic Masses
- •Isoechoic Masses
- •Hyperechoic Masses
- •Echogenic Masses
- •Irregular Masses
- •Differential Diagnosis of Focal Lesions
- •Diagnostic Methods
- •Suspected Diagnosis
- •3 Biliary Tree and Gallbladder
- •3.1 Biliary Tree
- •Thickening of the Bile Duct Wall
- •Localized and Diffuse
- •Bile Duct Rarefaction
- •Localized and Diffuse
- •Bile Duct Dilatation and Intraductal Pressure
- •Intrahepatic
- •Hilar and Prepancreatic
- •Intrapancreatic
- •Papillary
- •Abnormal Intraluminal Bile Duct Findings
- •Foreign Body
- •The Seven Most Important Questions
- •3.2 Gallbladder
- •Changes in Size
- •Large Gallbladder
- •Small/Missing Gallbladder
- •Wall Changes
- •General Hypoechogenicity
- •General Hyperechogenicity
- •General Tumor
- •Focal Tumor
- •Intraluminal Changes
- •Hyperechoic
- •Hypoechoic
- •Nonvisualized Gallbladder
- •Missing Gallbladder
- •Obscured Gallbladder
- •4 Pancreas
- •Diffuse Pancreatic Change
- •Large Pancreas
- •Small Pancreas
- •Hypoechoic Texture
- •Hyperechoic Texture
- •Focal Changes
- •Anechoic Lesion
- •Hypoechoic Lesion
- •Isoechoic Lesion
- •Hyperechoic Lesion
- •Irregular (Complex Structured) Lesion
- •Dilatation of the Pancreatic Duct
- •Marginal/Mild Dilatation
- •Marked Dilatation
- •5 Spleen
- •Nonfocal Changes of the Spleen
- •Diffuse Parenchymal Changes
- •Large Spleen
- •Small Spleen
- •Focal Changes of the Spleen
- •Anechoic Mass
- •Hypoechoic Mass
- •Hyperechoic Mass
- •Splenic Calcification
- •6 Lymph Nodes
- •Peripheral Lymph Nodes
- •Head/Neck
- •Extremities (Axilla, Groin)
- •Abdominal Lymph Nodes
- •Porta Hepatis
- •Splenic Hilum
- •Mesentery (Celiac, Upper and Lower Mesenteric Station)
- •Stomach
- •Focal Wall Changes
- •Extended Wall Changes
- •Dilated Lumen
- •Narrowed Lumen
- •Small/Large Intestine
- •Focal Wall Changes
- •Extended Wall Changes
- •Dilated Lumen
- •Narrowed Lumen
- •8 Peritoneal Cavity
- •Anechoic Structure
- •Hypoechoic Structure
- •Hyperechoic Structure
- •Anechoic Structure
- •Hypoechoic Structure
- •Hyperechoic Structure
- •Wall Structures
- •Smooth Margin
- •Irregular Margin
- •Intragastric Processes
- •Intraintestinal Processes
- •9 Kidneys
- •Anomalies, Malformations
- •Aplasia, Hypoplasia
- •Cystic Malformation
- •Anomalies of Number, Position, or Rotation
- •Fusion Anomaly
- •Anomalies of the Renal Calices
- •Vascular Anomaly
- •Diffuse Changes
- •Large Kidneys
- •Small Kidneys
- •Hypoechoic Structure
- •Hyperechoic Structure
- •Irregular Structure
- •Circumscribed Changes
- •Anechoic Structure
- •Hypoechoic or Isoechoic Structure
- •Complex Structure
- •Hyperechoic Structure
- •10 Adrenal Glands
- •Enlargement
- •Anechoic Structure
- •Hypoechoic Structure
- •Complex Echo Structure
- •Hyperechoic Structure
- •11 Urinary Tract
- •Malformations
- •Duplication Anomalies
- •Dilatations and Stenoses
- •Dilated Renal Pelvis and Ureter
- •Anechoic
- •Hypoechoic
- •Hypoechoic
- •Hyperechoic
- •Large Bladder
- •Small Bladder
- •Altered Bladder Shape
- •Intracavitary Mass
- •Hypoechoic
- •Hyperechoic
- •Echogenic
- •Wall Changes
- •Diffuse Wall Thickening
- •Circumscribed Wall Thickening
- •Concavities and Convexities
- •12.1 The Prostate
- •Enlarged Prostate
- •Regular
- •Irregular
- •Small Prostate
- •Regular
- •Echogenic
- •Circumscribed Lesion
- •Anechoic
- •Hypoechoic
- •Echogenic
- •12.2 Seminal Vesicles
- •Diffuse Change
- •Hypoechoic
- •Circumscribed Change
- •Anechoic
- •Echogenic
- •Irregular
- •12.3 Testis, Epididymis
- •Diffuse Change
- •Enlargement
- •Decreased Size
- •Circumscribed Lesion
- •Anechoic or Hypoechoic
- •Irregular/Echogenic
- •Epididymal Lesion
- •Anechoic
- •Hypoechoic
- •Intrascrotal Mass
- •Anechoic or Hypoechoic
- •Echogenic
- •13 Female Genital Tract
- •Masses
- •Abnormalities of Size or Shape
- •Uterus
- •Abnormalities of Size or Shape
- •Myometrial Changes
- •Intracavitary Changes
- •Endometrial Changes
- •Fallopian Tubes
- •Hypoechoic Mass
- •Anechoic Cystic Mass
- •Solid Echogenic or Nonhomogeneous Mass
- •14 Thyroid Gland
- •Diffuse Changes
- •Enlarged Thyroid Gland
- •Small Thyroid Gland
- •Hypoechoic Structure
- •Hyperechoic Structure
- •Circumscribed Changes
- •Anechoic
- •Hypoechoic
- •Isoechoic
- •Hyperechoic
- •Irregular
- •Differential Diagnosis of Hyperthyroidism
- •Types of Autonomy
- •15 Pleura and Chest Wall
- •Chest Wall
- •Masses
- •Parietal Pleura
- •Nodular Masses
- •Diffuse Pleural Thickening
- •Pleural Effusion
- •Anechoic Effusion
- •Echogenic Effusion
- •Complex Effusion
- •16 Lung
- •Masses
- •Anechoic Masses
- •Hypoechoic Masses
- •Complex Masses
- •Index
Index
Note: Illustrations are comprehensively referred to in the text. Therefore, significant items in illustrations have usually been given a page reference only in the absence of their concomitant mention in the text referring to that figure. Page references to tables are in bold and those to figures are in italics.
A |
|
|
|
|
|
ageing |
|
|
|
|
|
– aneurysms 8–11, 24, 519, 536 |
|
|
|||||
abdominal aorta see aorta |
|
– kidney |
323 |
|
|
– stenosis |
12 |
|
|
|
|
||||||||
|
– pancreas |
172 |
|
|
– – complete occlusion 17 |
|
|
||||||||||||
abdominal cavity see peritoneal cavity |
– spleen |
211 |
|
|
– – embolism 17, 22 |
|
|
|
|||||||||||
abortion, missed or incomplete |
453 |
– thyroid volume and |
477 |
– wall thickening 19–22 |
|
|
|||||||||||||
abscess |
|
|
|
|
|
agenesis, gallbladder |
150, 163 |
– see also para-aortic region |
|
|
|||||||||
– adrenal |
370 |
|
|
|
AIDS see HIV and AIDS |
aortointercaval lymph nodes 254–257 |
|||||||||||||
– hepatic |
90, 97, 113, 143 |
|
air see gas |
|
|
|
aplasia |
|
|
|
|
|
|
|
|||||
– intra-abdominal (in general) |
310 |
albumin, low plasma levels 301 |
– aortic |
5 |
|
|
|
|
|
|
|||||||||
– – gas-containing 312 |
|
|
alcoholic cirrhosis |
300, 313 |
– renal |
322–323 |
|
|
|
|
|||||||||
– ovarian |
465 |
|
|
|
alimentary tract see gastrointestinal tract |
– thyroid, unilateral 477, 486 |
|
|
|||||||||||
– pancreatic 181, 185 |
|
|
|
allergic vasculitis 21 |
|
– uterine |
447 |
|
|
|
|
||||||||
– perivascular |
27 |
|
|
|
allografts see transplantation and grafting |
– vaginal, incomplete |
447 |
|
|
||||||||||
– prostatic 423 |
|
|
|
alveolar cell carcinoma 544 |
appendicitis |
280 |
|
|
|
|
|||||||||
– pulmonary |
535, 550 |
|
|
alveolar echinococcosis/hydatid disease 91, 119 |
appendix |
280 |
|
|
|
|
|||||||||
– renal 348, 350, 356, 358 |
|
amiodarone-induced thyroiditis 485, 488 |
– mucocele |
276 |
|
|
|
|
|||||||||||
– renal pelvis |
393 |
|
|
|
ampulla of Vater, lesions near see periampul- |
arcuate arteries 321, 361 |
|
|
|||||||||||
– seminal vesicles 428 |
|
|
lary lesions |
|
|
arcuate ligament syndrome, median |
13 |
||||||||||||
– splenic |
214, 219, 220–221 |
|
amyloidosis |
|
|
arcuate uterus 446 |
|
|
|
||||||||||
– testicular 432 |
|
|
|
– intestinal |
286 |
|
|
arms, lymph nodes draining the 245–247 |
|||||||||||
– thyroid |
491, 495 |
|
|
|
– renal |
333 |
|
|
arteries |
|
|
|
|
|
|
|
|||
– tubo-ovarian 459, 465 |
|
– splenic |
207, 212 |
|
|
– anatomical anomalies and variants |
5–7 |
||||||||||||
absorption atelectasis |
537 |
|
– thyroid |
483, 503 |
|
|
– dilatation |
7–11 |
|
|
|
|
|||||||
acalculous cholecystitis |
152 |
|
analgesic nephropathy 336, 340, 341, 343, 361, |
– embolism see embolism |
|
|
|||||||||||||
accessory hepatic lobes |
59, 60 |
|
362 |
|
|
|
|
|
– stenosis see stenosis |
|
|
||||||||
accessory pancreatic duct 169 |
|
anaplastic tumors see undifferentiated/ana- |
– wall thickening 19–22 |
|
|
||||||||||||||
accessory spleen 250, 372, 374 |
|
plastic tumors |
|
|
– see also specific arteries |
|
|
||||||||||||
acinar cell carcinoma |
184 |
|
anastomotic stenosis |
18 |
arteriolosclerosis, renal 335 |
|
|
||||||||||||
acinus, hepatic 57 |
|
|
|
androblastoma 471 |
|
arteriosclerosis (incl. atherosclerosis) |
19–22 |
||||||||||||
acromegaly |
|
|
|
|
anechoicity (of lesions) |
– advanced lesions |
20 |
|
|
||||||||||
– goiter 483 |
|
|
|
|
– adrenal |
369–370 |
|
– complex lesions |
20 |
|
|
||||||||
– kidney enlargement |
330 |
|
– epididymis 434 |
|
|
– early lesions 19 |
|
|
|
|
|||||||||
adenocarcinoma |
|
|
|
– kidney 344–350 |
|
|
– Mönckeberg’s 22 |
|
|
|
|||||||||
– ductal see ductal carcinoma |
|
– liver |
88–95 |
|
|
– protruding lesions |
21 |
|
|
||||||||||
– endometrioid 465, 470 |
|
– lung |
534–536 |
|
|
– protruding plaques |
23 |
|
|
||||||||||
– gastric |
267, 270 |
|
|
|
– pancreas |
179–182, 195 |
– renal |
13, 335 |
|
|
|
|
|||||||
– intestinal 275 |
|
|
|
– peritoneal cavity |
298, 300–302, 310 |
– stenosis |
12, 13, 15, 17 |
|
|
||||||||||
– see also cystadenocarcinoma |
|
– pleural effusions |
524–526 |
– – aorta |
17 |
|
|
|
|
||||||||||
adenoma |
|
158, 159 |
|
|
– prostate |
423–424 |
|
– WHO definition |
19 |
|
|
|
|||||||
– gallbladder |
|
|
– scrotum |
435–436 |
|
arteriovenous (AV) fistula, splenic |
219 |
||||||||||||
– hepatic |
86, 98, 101–103, 103 |
|
– spleen |
213–215 |
|
|
arteriovenous (AV) malformations |
5–7, 26 |
|||||||||||
– oncocytic see oncocytoma |
|
– testes 431–432 |
|
|
– kidney 349 |
|
|
|
|
||||||||||
– pancreatic 183 |
|
|
|
– thyroid |
489–491 |
|
|
– liver 95 |
|
|
|
|
|
|
|||||
– parathyroid |
494, 500 |
|
|
aneurysms (arterial) 8–11 |
arteritis |
21 |
|
|
|
|
|
||||||||
– prostatic 407, 421, 424 |
|
– aortic |
8–11, 24, 519, 536 |
– giant-cell |
15, 21 |
|
|
|
|
||||||||||
– thyroid |
491–493, 501 |
|
– endoleaks after surgical repair 24 |
– Takayasu |
15, 21 |
|
|
|
|
||||||||||
– – regressive changes |
500 |
|
– false see pseudoaneurysms |
artifacts, bladder 408 |
|
|
|||||||||||||
adenomatous hyperplasia of endometrium 457 |
– hepatic artery 95, 249 |
asbestosis |
520, 522 |
|
|
|
|||||||||||||
adenomatous thyroid nodules and adenomas |
– renal artery 349 |
|
|
ascariasis |
141 |
|
|
|
|
||||||||||
492 |
|
|
|
|
|
– splenic artery 181 |
|
ascites see fluid collections |
|
|
|||||||||
– regressive changes |
500 |
|
– suture line 27 |
|
|
aspergilloma 535 |
|
|
|
|
|||||||||
adenomucinosis, diffuse peritoneal 307 |
– true 8–11 |
|
|
aspiration |
|
|
|
|
|
|
|||||||||
adenomyomatosis |
|
|
|
angiography, focal liver lesions 120 |
– fine-needle see fine-needle aspiration |
||||||||||||||
– gallbladder |
156, 157, 157 |
|
angiomyolipoma 352–353, 359 |
– of ovarian cyst, contraindicated |
473 |
||||||||||||||
– uterine |
450 |
|
|
|
|
angiomyoma, uterine |
447 |
– of pleural effusions |
524 |
|
|
||||||||
adhesions, chest wall |
545 |
|
annular pancreas 188 |
– of splenic abscess 221 |
|
|
|||||||||||||
adnexal lesions/masses (ovarian) 280 |
anorchism |
431 |
|
|
asplenism |
211 |
|
|
|
|
|||||||||
– inflammatory 465 |
|
|
|
antibiotic-associated colitis 286 |
atelectasis |
537 |
|
|
|
|
|||||||||
adrenal (suprarenal) glands 365–377 |
antibodies (autoimmune) to thyroid compo- |
atherosclerosis see arteriosclerosis |
|
|
|||||||||||||||
– anatomy 367 |
|
|
|
nents |
480, 481, 487 |
Atlanta classification of acute pancreatitis 174, |
|||||||||||||
– lesions |
250, 369–377 |
|
|
antral vascular ectasia, gastric 268 |
181 |
|
|
|
|
|
|
|
|||||||
– morphology |
368 |
|
|
|
aorta (including abdominal aorta) 1–29 |
atresia, uterine 447 |
|
|
|
||||||||||
– topography |
367 |
|
|
|
– anatomical anomalies and variants 5–6 |
atrophy |
|
|
|
|
|
|
|
||||||
adventitia, aortic 3 |
|
|
|
– anatomy and topography 1–2 |
– gallbladder, inflammatory 151 |
|
|
Index
553
Index
– intestine |
291 |
|
bleeding see hemorrhage |
|
|
carcinoma |
|
|
|
|
|||
– kidney 335, 336, 342–343, 363 |
blood |
|
|
|
|
– adrenal |
372, 375 |
|
|||||
– liver 76 |
|
|
|
– in bile (hemobilia) 135, 162 |
|
– biliary |
|
|
|
|
|||
– pancreas |
172, 200 |
|
– in peritoneal cavity (hemoperitoneum) 302, |
– – cholangiocellular see cholangiocellular |
|||||||||
– testes 431 |
|
|
305–306 |
|
|
|
carcinoma |
|
|
||||
– thyroid, in Hashimoto thyroiditis 480, 484 |
blood clot see clot |
|
|
|
– – gallbladder 118, 157, 159 |
||||||||
autoantibodies to thyroid components 481 |
blood flow patterns |
|
|
– – periampullary |
140, 197 |
||||||||
autoimmune disorders see Hashimoto |
– hepatic veins 61–62, 64, 67 |
|
– breast see breast cancer |
|
|||||||||
thyroiditis; immunological disease; poly- |
– portal veins 61–62, 64 |
|
|
– bronchial see lung cancer |
|||||||||
glandular autoimmune syndrome |
blood vessels/supply see arteries; vasculature; |
– esophageal see esophagus |
|||||||||||
axilla |
|
|
|
veins and specific vessels |
|
|
– gastric 267, 270 |
|
|
||||
– lymph nodes 245–247 |
bone fractures, rib/sternal |
513 |
|
– – scirrhous carcinoma 270, 274 |
|||||||||
– – regions |
234 |
|
bone marrow transplantation, graft-versus- |
– gynecological |
|
|
|||||||
– other structures 247 |
|
host disease 211 |
|
|
– – fallopian tubes |
459 |
|
||||||
|
|
|
|
borderline tumors |
|
|
|
– – ovarian |
465–468, 469, 470, 527 |
||||
B |
|
|
|
– ovarian |
467 |
|
|
|
– – uterine cervix |
457–458 |
|||
|
|
|
– pancreatic 192 |
|
|
|
– – uterine corpus |
450, 456 |
|||||
|
|
|
|
bowel see intestine |
|
|
– – vaginal |
443 |
|
|
|||
bacteria |
|
|
|
breast cancer (carcinoma) |
|
|
– hepatic metastases 96 |
|
|||||
– culture, focal liver lesions 120 |
– adrenal metastases 376 |
|
|
– hepatocellular (HCC) 86, 99, 103–105, 112, |
|||||||||
– gas-forming, kidney |
362 |
– cutaneous metastases 516 |
|
121, 131, 134, 137 |
|
|
|||||||
bacterial infection |
|
– pleural effusions 521 |
|
|
– intestinal |
275, 290 |
|
||||||
– peritonitis see peritonitis |
– splenic metastases 206 |
|
|
– pancreatic |
171, 183–184, 192, 193, 194 |
||||||||
– pyogenic see pyogenic lesions |
Brenner tumor 470 |
|
|
– – ductal |
139, 171, 183, 184, 192, 194 |
||||||||
balloon catheter, urinary 406 |
bronchi |
|
|
|
|
– prostatic |
405, 419–420, 421, 424, 425 |
||||||
bezoar 278 |
|
|
|
– carcinoma see lung cancer |
|
– – seminal vesicle infiltration 427, 428 |
|||||||
bicornuate uterus 446 |
|
– obstruction causing atelectasis 537 |
– pulmonary see lung cancer |
||||||||||
bifid ureter |
384 |
|
bronchoalveolar carcinoma 545, 546 |
|
– thyroid 493, 496–498, 504 |
||||||||
bifurcation, portal vein |
69 |
Budd–Chiari syndrome 37, 47 |
|
– urinary tract |
|
|
|||||||
bile |
|
|
|
bypass graft stenosis 18 |
|
|
– – polypoid (in bladder) 404–405, 407, 412 |
||||||
– blood in (hemobilia) |
135, 162 |
– suture complications 27 |
|
– – renal cell see renal cell carcinoma |
|||||||||
– leakage see bilioma; choleperitoneum |
– synthetic grafts |
22 |
|
|
– – urothelial 354, 355, 394 |
||||||||
– stasis (cholestasis) 142–145 |
|
|
|
|
|
– see also adenocarcinoma; choriocarcinoma; |
|||||||
bile ducts/vessels 100 |
|
C |
|
|
|
|
cystadenocarcinoma |
|
|||||
– abnormal and rare intraluminal findings |
|
|
|
|
carcinomatosis |
|
|
||||||
140–141 |
|
|
|
|
|
|
|
|
– peritoneal |
271, 273, 301, 304, 313, 314, 317, |
|||
– anatomy |
127–128 |
|
C-cell carcinoma, medullary thyroid |
496 |
465–466 |
|
|
|
|
||||
– anechoic masses 95 |
|
calcific stenosis, medial 22 |
|
– – mucinous 307 |
|
|
|||||||
– calculi see gallstones |
|
calcifications 228–229 |
|
|
– – septated ascites 310 |
|
|||||||
– carcinoma see cholangiocellular carcinoma |
– adrenal |
376 |
|
|
|
– pleural 521 |
|
|
|||||
– dilatation see dilatation |
– hepatic |
115 |
|
|
|
carcinosarcoma, uterine 450 |
|||||||
– echogenic masses 115 |
– pancreatic, in chronic pancreatitis |
178 |
cardia, gastric, carcinoma |
267, 268 |
|||||||||
– hamartoma (von Meyenburg complex) 66, |
– pleural |
520 |
|
|
|
cardiac... see heart |
|
|
|||||
112 |
|
|
|
– renal papillae 361 |
|
|
Caroli disease/syndrome 79, 115, 132 |
||||||
– hyperechoic masses |
112 |
– seminal vesicles |
428 |
|
|
carotid arteries |
|
|
|||||
– isoechoic masses 107 |
– splenic |
|
|
|
|
– stenosis |
13 |
|
|
||||
– pancreatic duct dilatation related to 196 |
– – artery 190 |
|
|
|
– stent 18 |
|
|
|
|
||||
– rarefaction |
132 |
|
– – hemangioma |
226 |
|
|
carotidynia, idiopathic 15 |
|
|||||
– topography |
128 |
|
– testicular 433 |
|
|
|
catheter |
|
|
|
|
||
– wall thickening 130–131, 142 |
– thyroid |
502 |
|
|
|
– splenic abscess drainage |
221 |
||||||
biliary tree |
127–145 |
|
– uterine myoma |
449 |
|
|
– urinary 406 |
|
|
||||
– anatomy |
127–128, 129 |
– venous |
36 |
|
|
|
caudate lobe 60, 71 |
|
|||||
– topography and morphology 128–129 |
– see also microcalcification |
|
– enlargement 37 |
|
|
||||||||
bilioduodenal stents 138 |
calcitonin |
477 |
|
|
|
– size determination 71 |
|
||||||
bilioma 90, 311 |
|
calculi (stones) |
|
|
|
caval vein, inferior see vena cava |
|||||||
biopsy see needle biopsy |
– biliary (choledocholithiasis) 115, 134, 135, |
cavities (pathological) |
|
||||||||||
bladder 398–414 |
|
136–137, 139 |
|
|
|
– prostatic |
423 |
|
|
||||
– artifacts 408 |
|
– pancreatic 199 |
|
|
|
– renal, in tuberculosis 348 |
|||||||
– cancer, lymph node metastases 255 |
– – in chronic pancreatitis |
178 |
|
– see also intracavitary lesions and masses |
|||||||||
– empty 400 |
|
|
– prostatic 426 |
|
|
|
cecal cancer, hepatic metastases 96 |
||||||
– indented |
402, 408 |
|
– seminal vesicles |
428 |
|
|
celiac axis |
|
|
|
|
||
– large 398–399 |
|
– urinary see urolithiasis |
|
|
– arteries |
|
|
|
|
||||
– partially contracted 401 |
– see also microlithiasis |
|
|
– – stenosis |
13 |
|
|
||||||
– shape 381 |
|
|
calices (renal), anomalies |
328 |
|
– – variant and duplicated |
6 |
||||||
– – changes |
401–402 |
|
– diverticula 328, 384 |
|
|
– lymph nodes 251–254 |
|
||||||
– shrunken |
400 |
|
– see also hydrocalices; megacalicosis; uroli- |
– – invasion around 240 |
|
||||||||
– urine reflux from 391–392 |
thiasis |
|
|
|
|
celiac disease 265, 283 |
|
||||||
– volume/size |
381 |
|
cancer see malignant tumor |
|
celiac trunk stenosis 14 |
|
|||||||
– – changes |
398–402 |
|
capsule |
|
|
|
|
cervix (uterine) 445 |
|
||||
– – estimation 398–399 |
– hepatic, injuries |
90 |
|
|
– carcinoma |
457–458 |
|
||||||
– wall see wall |
|
– splenic, lesions under see subcapsular lesions |
– inflammation (cervicitis) |
456 |
|||||||||
|
|
|
|
carbuncle, renal 358 |
|
|
– pregnancy in 453 |
|
554
chest wall 511, 513–517 |
|
|
“comet tails” |
|
– – metastases resembling 350 |
|
||||||||||
– adhesions 545 |
|
|
|
|
|
– gallbladder 156 |
|
– seminal vesicles |
427 |
|
||||||
– anatomy and topography 511 |
|
– hepatic parenchyma 114 |
– splenic 213–215 |
|
||||||||||||
– masses |
513–517 |
|
|
|
|
|
complex (echo) structures |
– – infective |
215 |
|
|
|||||
– – carcinoma (Pancoast tumor) 517, 544 |
– adrenal glands 374–375 |
– testicular |
431 |
|
|
|||||||||||
– morphology 511 |
|
|
|
|
|
– kidneys 356–358 |
|
– thyroid 489–490 |
|
|||||||
children (and juveniles) |
|
|
– lung 546–550 |
|
– – colloid cysts 489, 490, 499, 501 |
|
||||||||||
– lymphocytic thyroiditis |
484 |
|
– pleural effusions 528–529 |
– tubo-ovarian cysts 459 |
|
|||||||||||
– pancreas 173 |
|
|
|
|
|
compression |
|
– utricular |
424 |
|
|
|||||
– renal cysts 324 |
|
|
|
|
|
– atelectasis caused by (from pleural effusions) |
– vaginal wall |
443 |
|
|||||||
– see also neonatal hypothyroidism |
|
537 |
|
|
|
– venous compression by 38 |
|
|||||||||
cholangiocellular carcinoma (cholangiocarci- |
– gastric |
273 |
|
– see also cystic tumors; pseudocyst |
|
|||||||||||
noma) |
86, 131, 134, 137 |
|
|
– venous (incl. vena cava) 37–38 |
cystadenocarcinoma |
|
||||||||||
– Klatskin type 50, 131, 133, 137, 137 |
|
computed tomography (CT) |
– ovarian 463, 470 |
|
||||||||||||
cholangiofibroma (bile duct hamartoma) 66, |
– chronic pancreatitis 177 |
– pancreatic |
180, 192, 369 |
|
||||||||||||
112 |
|
|
|
|
|
|
– focal liver lesions |
120 |
cystadenoma |
|
|
|
||||
cholangitis 248 |
|
|
|
|
|
– ovarian tumor 473 |
– ovarian 463, 470 |
|
||||||||
– acute suppurative |
130 |
|
|
concavities, bladder |
413 |
– pancreatic |
180, 183, 192 |
|
||||||||
– primary sclerosing |
130, 132, 142 |
|
congenital anomalies and variants (incl. mal- |
cystic duct |
146 |
|
|
|||||||||
cholecystectomy 132, 163, 196 |
|
formations) |
|
– dilation |
133, 136, 144 |
|
||||||||||
cholecystitis (gallbladder inflammation) |
151 |
– aorta and arteries |
5–7, 26 |
cystic fibrosis, pancreatic fibrosis 176 |
|
|||||||||||
– acalculous 152 |
|
|
|
|
|
– arteriovenous see arteriovenous malforma- |
cystic glandular hyperplasia, endometrial |
457 |
||||||||
– acute 152 |
|
|
|
|
|
tions |
|
|
|
cystic malformation of kidney 324–325 |
|
|||||
– chronic |
152, 154 |
152, 157 |
|
– gallbladder 146 |
|
cystic tumors/neoplasms |
|
|||||||||
– emphesematous |
|
– liver 59, 95 |
|
– adrenal 370 |
|
|
|
|||||||||
– focal 155 |
|
|
|
|
|
– pancreas 187–188 |
– kidney |
|
|
|
|
|
||||
– phlegmonous 152, 153 |
|
|
– – cyst 179, 180 |
|
– – carcinoma |
347, 352, 357 |
|
|||||||||
– xanthogranulomatous 152 |
|
– spleen |
203 |
|
– – nephroma |
344, 345, 354 |
|
|||||||||
choledochocele 133 |
|
|
|
|
– urinary tract 383–386 |
– lung 536 |
|
|
|
|
||||||
chole(docho)lithiasis see gallstones |
|
– – kidney 322–323, 325–329, 383 |
– ovaries 463, 470 |
|
||||||||||||
choleperitoneum 305 |
|
|
|
– uterus |
446 |
|
– pancreas |
180, 192–194 |
|
|||||||
cholestasis 142–145 |
|
|
156, 157 |
|
– vagina |
443 |
|
cystoma, mucinous see mucinous cystic neo- |
||||||||
cholesteatosis, gallbladder |
|
– veins 29–31 |
|
plasms |
|
|
|
|
|
|||||||
cholesterol crystals |
162 |
158, 159 |
|
– – portal 209 |
|
cytology, focal liver lesions 120 |
|
|||||||||
cholesterol pseudopolyps |
|
congestion |
|
|
|
|
|
|
|
|
||||||
choriocarcinoma (chorioepithelioma) 457 |
– cardiac |
271 |
|
D |
|
|
|
|
|
|||||||
chromophobe cell carcinoma 352 |
|
– liver see liver |
|
|
|
|
|
|
||||||||
chyloperitoneum 306 |
|
|
524 |
– renal, in heart failure 332 |
|
|
|
|
|
|
||||||
chylothorax (chylous pleural effusions) |
– renal vein |
349 |
|
de Quervain thyroiditis 482, 488, 495, 505 |
||||||||||||
cicatricial stenosis (biliary tree) 135 |
|
– splenic |
209 |
|
– focal 495 |
|
|
|
|
|||||||
circumscribed change see focal change |
|
constitutionally large kidney 330 |
– subacute |
482 |
|
|
||||||||||
cirrhosis 42, 45, 76, 82–84, 132, 143, 300, 303, |
contraceptive device, intrauterine (IUD) 451, |
deep vein thrombosis 34 |
|
|||||||||||||
313 |
|
|
|
|
|
|
453 |
|
|
|
degenerating myoma 448–449, 449 |
|
||||
– fatty 75 |
|
|
151 |
|
convexities, bladder |
413 |
dermoid, ovarian |
472 |
|
|||||||
– gallbladder changes |
|
coprostasis |
290 |
|
diabetic nephropathy 331, 336, 338, 340, 361, |
|||||||||||
– parenchymal assessment 65 |
|
corpus librum 436 |
|
362 |
|
|
|
|
|
|||||||
– peritoneal fluid 300, 303, 313 |
|
corpus luteum cyst |
461 |
diaphragm |
511, 512 |
|
||||||||||
– splenomegaly 209 |
|
|
|
|
Couinaud segmental anatomy of liver 58 |
– slips 113 |
|
|
|
|
||||||
clear cell carcinoma/tumor |
|
Crohn disease 283–285 |
diffuse or general changes |
|
||||||||||||
– ovarian |
470 |
|
|
|
|
|
crural thrombosis 34 |
– bladder wall |
410–411 |
|
||||||
– renal 352 |
|
|
|
|
|
cryptorchidism 431 |
– gallbladder 151–160 |
|
||||||||
clot (blood) |
|
|
|
|
|
CT see computed tomography |
– – tumors 156–157 |
|
||||||||
– bladder |
403, 405, 406, 413 |
|
culture, focal liver lesions 120 |
– kidney 329–343 |
|
|||||||||||
– kidney |
392 |
|
|
|
|
|
cutaneous metastases 515 |
– liver 66, 70–86, 117, 118 |
|
|||||||
– ureter 395 |
|
|
|
|
|
cyst(s) (and cystic masses) |
– pancreas |
170–178, 195 |
|
|||||||
coarctation, aortic |
5 |
|
|
|
|
– adrenal |
369 |
|
– peritoneal cavity 298–308 |
|
||||||
colic, urinary stone |
388 |
|
|
– epididymal 434 |
|
– pleura 520–523 |
|
|
||||||||
colitis |
|
|
|
|
|
|
– hemorrhagic see hemorrhagic cysts |
– seminal vesicles |
426–427 |
|
||||||
– pseudomembranous |
286 |
|
– hepatic |
86, 88–89, 90–94, 309 |
– spleen 206–207, 215 |
|
||||||||||
– ulcerative 285 |
|
|
|
|
|
– – complicated 98 |
|
– – calcification 228 |
|
|||||||
collateral vessels in portal hypertension |
41, 47 |
– – hydatid (echinococcosis) 90–91, 119, 345 |
– testes 430–431 |
|
|
|||||||||||
collecting duct carcinoma |
352 |
|
– hydatid see hydatid disease |
– thyroid gland 479–489 |
|
|||||||||||
colloid cysts 489, 490, 499, 501 |
|
– lung 519, 535 |
|
diffuse peritoneal adenomucinosis 307 |
|
|||||||||||
colloid goiter, diffuse |
480 |
|
|
– ovarian |
461–463 |
|
digestive tract see gastrointestinal tract |
|
||||||||
colon 265 |
|
|
|
|
|
– – aspiration, contraindicated 473 |
dilatations |
|
|
|
|
|
||||
– anatomy and topography 261–262 |
|
– pancreatic |
179, 180, 181, 185 |
– bile duct |
132–140 |
|
||||||||||
– cancer |
275 |
|
|
|
|
|
– perirenal |
345 |
|
– – in differential diagnosis of cholestasis |
142 |
|||||
– – adrenal metastases |
372 |
|
– peritoneal cavity filled with contents |
– gastric 272–274 |
|
|
||||||||||
– – hepatic metastases |
113, 122 |
|
following rupture of 302 |
– intestinal |
287–290 |
|
||||||||||
– diverticula 278 |
|
|
|
|
|
– renal 324–325, 344–348, 351, 369 |
– pancreatic duct |
195–199 |
|
|||||||
– morphology 262 |
|
|
|
|
|
– – carcinoma in 347 |
– seminal vesicles |
427 |
|
|||||||
– pseudodiverticula |
279 |
|
|
– – hemorrhage in |
351, 357, 359, 394 |
– urinary tract |
384–394 |
|
Index
555
Index
– vascular |
|
|
|
|
– renal pelvis (pyelectasis) 349, 364, 386 |
esophagus |
|
|
|
||||||||
– – arterial (incl. aorta) 7–11 |
– vas deferens 429 |
|
|
|
|
– anatomy and tomography |
261 |
||||||||||
– – renal 349 |
|
|
|
|
– venous (venectasia) 33 |
|
|
|
– cancer (carcinoma) |
|
|
|
|||||
– – veins see veins |
|
|
– – renal |
349 |
|
|
|
|
– – hepatic metastases |
96 |
|
|
|||||
– see also ectasia |
|
|
|
– see also atelectasis |
|
|
|
– – thyroid invasion 498 |
|
|
|||||||
dissection (arterial) |
15 |
|
ectopia |
|
|
|
|
|
|
– morphology 262 |
|
|
|
||||
– aneurysmal 8, 9 |
|
|
– kidney |
323, 326 |
|
|
|
|
– peristalsis 263 |
|
|
|
|||||
– aortic |
9, 15 |
|
|
|
|
– pregnancy |
453 |
|
|
|
|
– varices |
45 |
|
|
|
|
– – intimal 25 |
|
|
|
|
– – cervix |
453 |
|
|
|
|
extremity lymph nodes |
245–247 |
|||||
diverticula |
|
|
|
|
– – fallopian tubes |
459 |
|
|
|
exudates |
|
|
|
|
|||
– gastric |
278 |
|
|
|
|
– thyroid |
485 |
|
|
|
|
– peritoneal 303 |
|
|
|
||
– intestinal 278 |
|
|
|
– ureter 391, 424 |
|
|
|
|
– pleural |
524, 526 |
|
|
|
||||
– – inflammation (diverticulitis) 279 |
edema |
|
|
|
|
|
|
|
|
|
|
|
|||||
– urinary tract |
|
|
|
|
– bladder wall 412 |
|
|
|
|
F |
|
|
|
|
|||
– – bladder 401, 413–414 |
|
– gallbladder wall |
150 |
|
|
|
|
|
|
|
|||||||
– – renal caliceal |
328, 384 |
|
– gastric wall |
271 |
|
|
|
|
|
|
|
|
|
||||
– – ureter 384 |
|
|
|
|
– hepatic |
78 |
|
|
|
|
|
fallopian tubes 458–459 |
|
|
|||
– see also pseudodiverticula |
– pancreatic |
170 |
|
|
|
|
– abscess involving ovaries and 459, 465 |
||||||||||
diverticulosis 279 |
|
|
|
effusions |
|
|
|
|
|
|
– cysts involving ovaries and |
459 |
|||||
dorsal (pancreatic) anlage |
187 |
– peritoneal |
|
|
|
|
|
– see also hematosalpinx |
|
|
|||||||
doubling (congenital) see duplications |
– – exudates |
303 |
|
|
|
|
familial nephronophthisis 324 |
||||||||||
drainage of splenic abscess |
221 |
– – transudates 300 |
|
|
|
fat necrosis, pancreatic/peripancreatic 171, 190 |
|||||||||||
dromedary hump (kidney) |
350 |
– pleural see pleura |
|
|
|
fatty change (steatosis) |
|
|
156, 157 |
||||||||
drug-induced thyroiditis 485, 488 |
elastosonography 419–420 |
|
|
|
– gallbladder (cholesteatosis) |
||||||||||||
ductal carcinoma/adenocarcinoma (of pan- |
– prostatic carcinoma 422 |
|
|
|
– liver (steatosis hepatis) 72–75, 79 |
||||||||||||
creas) |
139, 171, 183, 184, 192, 194 |
embolism |
|
|
|
|
|
|
– – focal |
74–75, 80–81, 86, 100, 114 |
|||||||
– cystic |
192, 193 |
|
|
|
– arterial |
17, 22 |
|
|
|
|
– – hepatitis (steatohepatitis) |
73–74 |
|||||
duodenum 200 |
|
|
|
– – aorta |
17, 22 |
|
|
|
|
– – infiltration see infiltration |
|
||||||
– anatomy and topography |
261 |
– – renal artery 334–335 |
|
|
|
fatty degradation of liver 65 |
|
||||||||||
– diverticula 278 |
|
|
|
– gas, hepatoportal |
81, 117 |
|
|
|
fecal impaction (coprostasis) |
290 |
|||||||
– gallstones in |
278 |
|
|
– pulmonary |
538–544 |
|
|
|
females |
|
|
|
|
||||
– gut signature |
264 |
|
– see also thromboembolism |
|
|
|
– genital tract see genital tract |
||||||||||
– morphology |
262 |
|
|
emphesematous cholecystitis 152, 157 |
|
– periods of life 441 |
|
|
|
||||||||
– stenosis 317 |
|
|
|
|
emphysematous pyelonephritis |
350, 362 |
fetal lob(ul)ation of the kidney 328, 350 |
||||||||||
– ulcer, perforated |
305, 306, 308, 312 |
empty bladder 400 |
|
|
|
fibrin strands/bodies |
|
|
|
||||||||
duplications (doubling) |
|
empyema, pleural (pyothorax) |
522, 550 |
– pancreatitis 313 |
|
|
|
||||||||||
– aortic |
5 |
|
|
|
|
endocrine laboratory work-up of adrenal inci- |
– pleura |
519 |
|
|
|
||||||
– arterial 6 |
|
|
|
|
dentaloma |
373 |
|
|
|
|
fibroids, uterine (myoma) 447, 448–449, 450 |
||||||
– renal 325–326, 330, 355, 383 |
endocrine and neuroendocrine tumors |
|
fibroleiomyoma, uterine (fibroids; myoma) |
||||||||||||||
– ureter |
384 |
|
|
|
|
– hepatic metastases 95, 122 |
|
|
|
447, 448–449, 450 |
|
|
|
||||
– vagina |
443 |
|
|
|
|
– kidney |
352 |
|
|
|
|
fibrolipomatosis, pancreatic |
175 |
||||
– vena cava 29 |
|
|
|
– pancreas 182, 183, 184 |
|
|
|
– chronic pancreatis vs. 177 |
|
||||||||
dysgerminoma |
472 |
|
– see also multiple endocrine neoplasia synd- |
fibroma |
|
|
|
|
|||||||||
dysontogen(et)ic cysts |
|
rome |
|
|
|
|
|
368 |
– bladder |
407 |
|
|
|
||||
– kidney |
344 |
|
|
|
|
endocrine symptoms of adrenal disease |
– ovarian |
471 |
|
|
|
||||||
– spleen |
213 |
|
|
|
|
endodermal (entodermal) sinus tumor |
472 |
– tunica albuginea 436 |
|
|
|
||||||
dysplastic kidneys |
|
323 |
|
endometrioid tumor (adenocarcinoma) |
465, |
fibromatosis, pancreatic |
175–176 |
||||||||||
– cystic (Potter type II syndrome) 324 |
470 |
|
|
|
|
|
|
fibromuscular dysplasia |
15 |
|
|
||||||
|
|
|
|
|
|
endometriosis 450, 464 |
|
|
|
fibrosis |
|
|
|
|
|||
E |
|
|
|
|
|
– cysts 464 |
|
|
|
|
|
– liver 42, 79 |
|
|
|
||
|
|
|
|
|
endometritis |
456 |
|
|
|
|
– pancreatic |
|
|
|
|||
echinococcosis see hydatid disease |
endometrium 444–445 |
|
|
|
– – in chronic pancreatitis 178 |
||||||||||||
– changes |
454–458 |
|
|
|
– – in hemochromatosis or cystic fibrosis 176 |
||||||||||||
echo-free lesions and masses see anechoicity |
– – hyperplasia see hyperplasia |
|
|
|
– pleural |
522–523 |
|
|
|
||||||||
echogenicity |
|
|
|
|
– – polyps 453 |
|
|
|
|
– retroperitoneal 28, 38, 391 |
|
||||||
– bladder lesions |
408–409 |
|
– postmenopausal |
454, 474 |
|
|
|
fibrothorax 528 |
|
|
|
||||||
– epididymis 436 |
|
|
|
endoscopic retrograde cholangiopancreato- |
fibrous pseudotumor 436 |
|
|
||||||||||
– focal liver masses |
87, 114–116 |
graphy (ERCP) in chronic pancreatitis |
177 |
FIGO staging |
|
|
|
||||||||||
– – metastases |
97 |
|
|
endovascular stents see stents |
|
|
|
– ovarian cancer 466, 468 |
|
|
|||||||
– gut signature and |
263 |
|
enteric intussusception 277 |
|
|
|
– uterine cervix carcinoma |
457 |
|||||||||
– lymph node abnormalities 237 |
enteritis (small bowel inflammation) 282, 288 |
– uterine corpus carcinoma |
456 |
||||||||||||||
– ovaries 464–473 |
|
|
– Crohn disease 285 |
|
|
|
fine-needle aspiration (FNA) |
|
|||||||||
– pleural effusions |
526–527 |
enterocolitis, pseudomembranous |
286 |
|
– adrenal gland 373 |
|
|
|
|||||||||
– prostatic lesions |
423, 426 |
entodermal sinus (yolk sac) tumor |
472 |
|
– ascites (= paracentesis) 298, 299 |
||||||||||||
– renal structures |
361–363 |
epididymis 434 |
|
|
|
|
– thyroid |
492 |
|
|
|
||||||
– testicular lesions |
433 |
|
– anatomy/topography 429 |
|
|
|
– – carcinoma 497 |
|
|
|
|||||||
– uterus |
445 |
|
|
|
|
epididymitis |
434 |
|
|
|
|
fistula |
|
|
|
|
|
– see also anechoicity; hyperechoicity; hypo- |
epithelial cystic pancreatic lesions |
192 |
|
– in Crohn disease 284, 285 |
|
||||||||||||
echoicity; isoechoicity |
|
epithelial tumors |
|
|
352 |
– splenic arteriovenous |
219 |
|
|
||||||||
ectasia |
|
|
|
|
|
– mixed mesenchymal and, kidney |
flat bladder tumors 411, 412 |
|
|||||||||
– aortic |
7 |
|
|
|
|
– ovarian |
469, 470 |
|
|
|
|
|
|
|
|
|
|
– gastric antral |
268 |
|
|
|
|
|
|
|
|
|
|
|
|
|
556
fluid collections and fluid-filled structures |
– thickness (normal) |
146 |
|
|
|
gut signature |
262–263 |
|
|||||||||||
– biliary system 143 |
|
|
– topography 148 |
|
|
|
|
|
– see also gastrointestinal tract |
|
|||||||||
– extraperitoneal/extra-abdominal 296, 308, |
– wall 151 |
|
|
|
|
156, 159 |
|
gynecology see genital tract, female |
|
||||||||||
316–316 |
|
|
|
– – polypoid lesions |
|
|
|
|
|
|
|
||||||||
– in gastrointestinal tract |
|
– wall changes |
151–160 |
|
|
|
|
|
|
|
|
|
|||||||
– – bowel loops 28, 265 |
|
|
– – thickening |
42, 151, 152, 153, 154, 157 |
H |
|
|
|
|
|
|||||||||
– – differentiation from extraluminal fluid |
gallstones (choledocholithiasis) |
115, 134, 135, |
|
|
|
|
|
|
|||||||||||
316–318 |
|
|
160–161, 166 |
|
|
|
|
|
|
|
Hach classification of greater saphenous insuf- |
||||||||
– pancreas |
181 |
|
|
– in duodenum |
278 |
|
|
|
|
ficiency |
33 |
|
|
|
|
||||
– peritoneal cavity (ascites) |
295 |
– gallbladder perforation with |
154, 274 |
hamartoma |
|
|
|
|
|||||||||||
– – benign vs. malignant, differentiation |
– small/minute (microliths) |
135, 157, 160, 161 |
– bile duct 66, 112 |
|
|
||||||||||||||
315–316 |
299, 300 |
gas (incl. air) |
|
|
|
|
|
|
|
– splenic |
227 |
|
|
|
|
||||
– – differential diagnosis |
– abscess containing |
312 |
|
|
|
Hashimoto (autoimmune/lymphocytic) |
|
||||||||||||
– – diffuse changes and |
298–299 |
– bile duct (pneumobilia) 140 |
|
thyroiditis (AIT) 480, 483–486, 506 |
|
||||||||||||||
– – fine-needle paracentesis 298, 299 |
– intrahepatic accumulation |
116, 117 |
– acquired 483–486 |
|
|
||||||||||||||
– – in peritoneal carcinomatosis 304 |
– pancreatic duct |
190 |
|
|
|
– Graves disease vs. 482 |
|
||||||||||||
– – septated 310 |
|
|
– peritoneal cavity (pneumoperitoneum) 296, |
– hypertrophic |
480 |
|
|
||||||||||||
– – in splenic infarction |
220 |
307 |
|
|
|
|
|
|
|
|
head and neck |
|
|
|
|||||
– see also edema; effusions |
|
– pleural cavity (pneumothorax) 529 |
– lymph nodes |
241–245 |
|
||||||||||||||
focal change (circumscribed/localized change) |
gas embolism, hepatoportal |
81, 117 |
– – topography |
233–234 |
|
||||||||||||||
– bile duct |
132 |
|
|
gas-forming bacteria, kidney |
362 |
– other structures 244 |
|
||||||||||||
– bladder 411–414 |
|
|
gastric... see stomach |
|
|
|
|
heart (cardiac) cavity |
536 |
|
|||||||||
– gallbladder 155–157 |
|
|
gastrinoma |
182 |
|
|
|
|
|
|
heart (cardiac) failure |
301, 312 |
|
||||||
– – tumors |
157–160 |
|
|
gastritis (inflammation of stomach) 271, 272 |
– cirrhosis in (= cardiac cirrhosis) 77 |
|
|||||||||||||
– intestinal wall 274–281 |
|
gastroduodenal artery 170 |
|
|
|
– congestive (cardiac congestion), gastric wall |
|||||||||||||
– kidney |
344–363 |
|
|
gastrointestinal tract |
259–292 |
|
thickening 271 |
151 |
|
||||||||||
– liver 86–122 |
|
|
– anatomy |
261–262 |
|
|
|
|
– gallbladder changes |
|
|||||||||
– – fatty change 74–75, 80–81, 86, 100, 114 |
– functions |
261 |
|
|
|
|
|
|
– peritoneal fluid 301, 312 |
|
|||||||||
– pancreas |
179–194 |
|
|
– malignant tumors see malignant tumors |
– renal congestion in |
332 |
|
||||||||||||
– peritoneal cavity 308–312 |
– morphology |
262–265 |
|
|
|
– right-sided (ventricular) 301, 312, 337 |
|
||||||||||||
– prostate 423–426 |
|
|
– perforation see perforation |
|
|
hemangioma |
|
|
|
|
|||||||||
– seminal vesicles 427–428 |
– topography 261–262 |
|
|
|
– bladder |
407 |
|
|
|
||||||||||
– spleen |
213–229 |
|
|
– transport and propulsion, disruption/impair- |
– hepatic |
86, 107–111, 121 |
|
||||||||||||
– testes |
431–433 |
|
|
ment |
316 |
|
|
|
|
|
|
|
– – atypical 100, 106, 108, 110–112 |
|
|||||
– thyroid 489–494 |
|
|
– – causes |
|
|
|
|
|
|
|
– splenic |
225–227 |
|
|
|||||
focal nodular hyperplasia/FNH (liver) 86, 99, |
– – in intestine |
288, 316 |
|
|
|
– thyroid |
503 |
|
|
|
|
||||||||
101–103, 101, 112, 121 |
|
|
gastrosplenic ligaments 204 |
|
|
– uterine |
447 |
|
|
|
|
||||||||
follicles |
|
|
|
|
genital (reproductive) tract |
416–474 |
hemangiomyolipoma |
360 |
|
||||||||||
– ovarian 460 |
|
|
– female (and gynecology) |
439–474 |
hematocele 436 |
|
|
||||||||||||
– – cystic (follicular cysts) 461, 499 |
– – appearance |
441 |
|
|
|
|
hematocolpos |
442 |
|
|
|||||||||
– – graafian |
454, 460, 461 |
|
– – topography |
441 |
|
|
|
|
hematological malignancy, splenomegaly |
210 |
|||||||||
– thyroid 477 |
|
|
– – transabdominal ultrasound |
441 |
hematoma |
|
|
|
|
||||||||||
follicular thyroid adenoma |
491–492, 501 |
– male 416–437 |
|
|
|
|
|
|
– intra-abdominal 311 |
|
|||||||||
follicular thyroid carcinoma |
493, 496, 504 |
germ cell tumor |
|
|
|
|
|
|
– – hepatic 89–90, 98, 106–107 |
|
|||||||||
foreign bodies/objects |
|
|
– ovarian 469, 472 |
|
|
|
|
– – intestinal |
276 |
|
|
||||||||
– bile duct |
140–141 |
|
|
– testicular |
239, 432 |
|
|
|
|
– – renal |
348, 350, 357 |
|
|||||||
– bladder 409 |
|
|
giant-cell arteritis |
15, 21 |
|
|
|
– – splenic 214, 222 |
|
|
|||||||||
– intestine |
278, 290 |
|
|
giant hemangioma |
108, 109 |
|
|
– perivascular |
27 |
|
|
||||||||
– liver 116 |
|
|
|
glomerulonephritis |
|
|
|
|
|
– rib fracture |
514 |
|
|
||||||
fractures, rib/sternal 513 |
|
– acute 333, 340 |
|
|
|
|
|
|
– testicular 432 |
|
|
||||||||
functional disorder of gastric emptying 272 |
– chronic 336, 340 |
|
|
|
|
hematometra |
443, 447 |
|
|||||||||||
functional hyposplenism |
211 |
glucagonoma 182 |
|
|
|
|
|
hematoperitoneum 222 |
|
||||||||||
functional ovarian cysts |
461–462 |
goiter |
|
|
|
|
|
|
|
|
hematosalpinx |
443, 459 |
|
||||||
fusion anomalies |
|
|
– in acromegaly |
483 |
|
|
|
|
hemobilia |
135, 162 |
|
|
|||||||
– müllerian duct 443, 446 |
|
– diffuse colloid |
480 |
|
|
|
|
hemochromatosis 75, 79, 172, 176 |
|
||||||||||
– renal 327–328 |
|
|
– diffuse parenchymatous |
479–480 |
hemolytic disorders, splenic enlargement |
208 |
|||||||||||||
|
|
|
|
|
– nodular 475, 483, 490, 502–503 |
hemoperitoneum 302, 305–306 |
|
||||||||||||
G |
|
|
|
|
– – regressive 501, 503 |
|
|
|
hemorrhage (bleeding) |
|
|||||||||
|
|
|
|
– Riedel 483 |
|
|
|
|
|
|
|
– adrenal |
370 |
|
|
|
|
||
gallbladder |
146–165 |
|
|
graafian follicle |
454, 460, 461 |
|
– hepatic |
89–90, 98, 106–107 |
|
||||||||||
|
|
graft-versus-host disease in allogeneic bone |
– pancreatic pseudocyst 192 |
|
|||||||||||||||
– anatomy |
146 |
|
|
marrow transplantation |
211 |
|
– splenic |
|
|
|
|
|
|||||||
– – variants |
146 |
|
|
– see also bypass graft; transplantation |
– – with metastases 224 |
|
|||||||||||||
– carcinoma 118, 157, 159 |
|
grafting see transplantation and grafting |
– – subcapsular |
219 |
|
|
|||||||||||||
– hepatized |
107 |
|
|
granulomas, cutaneous 515 |
|
|
hemorrhagic cysts (intracystic hemorrhage) |
||||||||||||
– large 148–149 |
|
|
granulomatous disease, splenic |
207 |
– ovarian |
461 |
|
|
|
|
|||||||||
– malposition 164 |
|
|
granulosa cell tumors 471 |
|
|
|
– renal 351, 357, 359, 394 |
|
|||||||||||
– missing 150, 163 |
|
|
Graves disease |
481–482, 506 |
|
– thyroid |
489, 490, 499, 501 |
|
|||||||||||
– nonvisualized 163 |
|
|
groin |
|
|
|
|
|
|
|
|
hemorrhagic necrotizing pancreatitis 181 |
|
||||||
– obscured |
164 |
|
|
– lymph nodes |
245–247 |
|
|
|
hemorrhagic pleural effusions 524 |
|
|||||||||
– sludge |
161–162, 166 |
|
|
– other structures |
247 |
|
|
|
hepatic... see below and liver |
|
– small 150
Index
557
Index
hepatic artery 57
–aneurysms 95, 249
–topography 128
–variant anatomy 59
hepatic veins (liver veins and branches) 58, 60,
66–67
–anechoic masses 95
–in cirrhosis 83
–flow patterns 61–62, 64, 67
–hypoechoic masses 100 hepatitis 248
–acute 78
–– gallbladder changes 151
–chronic 82
–viral 78, 143
–see also steatohepatitis hepatocellular carcinoma (HCC) 86, 99,
103–105, 112, 121, 131, 134, 137 hepatomegaly (liver enlargement) 70–75 hepatosplenomegaly 50, 208, 210 hereditary hemorrhagic telangiectasia 94 hernia (abdominal) 257, 281, 289, 436 heroin-induced nephropathy 333
hilar sign 235, 242, 245 histiocytoma, malignant 545 histo(patho)logy
–liver lesions (focal) 120
–– carcinoma 99
–ovarian (normal histology) 460
–ovarian tumors 469–472
–– classification 469
–pancreatic cancer classification 183
–pleura 511
–prostatitis 421
–thyroid
–– carcinoma 496
–– nodules 492
–uterus 444
–– carcinoma 456
HIV and AIDS 248
–nephropathy 333 Hodgkin disease
–cutaneous involvement 516
–lymph node involvement 239, 243–244
–splenic involvement 210
hormones
–sex 441, 460
–thyroid 477 horseshoe shape
–kidney (malformation) 28, 327
–thyroid 477
human immunodeficiency virus see HIV hydatid disease (hydatid cyst; echinococcosis)
–kidney 345
–liver 90–91, 119
–pancreas 179
–spleen 215 hydrocalices 349 hydrocele 435, 436
hydronephrosis 349, 385, 387, 389, 390 hydropic gallbladder 149, 152
hymen, imperforate 442–443 hyperechoicity (high echogenicity)
–adrenal 375–377
–arteriosclerotic lesions (early stages) 19
–gallbladder 160–161
–– diffuse 154–160
–– focal 155–157
–liver, diffuse 79
–liver, focal masses 107–114
–– hepatocellular carcinoma 104, 112
–pancreas 175–178, 189–191, 195
–peritoneal cavity 298, 307–308, 311–312
–spleen 225–229
–thyroid 489, 501–504
–urinary tract
–– bladder 406–407
–– kidney 258–260, 338–343
–– renal pelvis/ureter 395–397 hyperplasia
–adrenal 370
–endometrial 462, 467
–– adenomatous 457
–– cystic glandular 457
–focal nodular (FNH) 86, 99, 101–103, 101, 112, 121
–parathyroid 477
–prostatic, benign (BPH) 407, 417, 418, 419, 421, 424, 425, 426
–– surgical capsule 426
–thyroid 477
–– in Hashimoto thyroiditis 480 hypersplenism, nodular 227 hypertension, portal 41–47, 207, 209 hyperthyroidism 504–506
–amiodarone-induced 485, 488
–Graves disease 481–482
–transient, chronic thyroiditis with 487 hypertrophic Hashimoto thyroiditis 480 hypertrophic pyloric stenosis 270 hypertrophy
–bladder wall 410, 411, 414
–intestinal wall 284
hypervascularization see vascularization hypoalbuminemia 301
hypoechoicity
–adrenal 370–373
–epididymis 434
–fallopian tubes 458–459
–gallbladder 161–162
–– focal 155–157
–– general 151–153
–liver
–– diffuse 77–78
–– focal masses 92, 96–100, 99, 104
–lung 537–546
–pancreas 173–175, 182–188, 195
–peritoneal cavity 298, 310–311
–scrotum 435–436
–seminal vesicles 426–427
–spleen 215–225
–testes 431–432
–thyroid 487–489, 491–498
–urinary tract 392–394
–– bladder 402–405
–– kidney 337, 350–356, 392–393 hypogonadism 431
hypoplasia
–aortic 5
–portal vein 209
–renal 323, 334
–uterine 447
hyposplenism, functional 211 hypothyroidism
–neonatal 485
–radiation-induced 485, 489 hypoxemic renal shock 338
I
ileitis, terminal 284 ileocecal valve
–intussusception 277
–lymphoma bowel 276 ileum
–anatomy and topography 261
–morphology 262
iliac artery, internal 444 iliac region
–lymph nodes 254–256
–other structures 255 iliac vein anomalies 30
immunological disease (incl. autoimmune disorders)
–liver 82
–pancreas 175
–spleen 211
–splenic enlargement due to 208
–thyroid 480–482, 483–484, 484, 487, 488, 504, 505
–– neonatal 485
–vasculitis 15, 21
imperforate hymen 442–443 impression, gastric 273 incidentaloma, adrenal 372 indented bladder 402, 408 infarction
–pulmonary 538–544
–renal 351
–splenic 214, 217–220
–testicular 432 infection
–bypass graft 27
–lymphadenopathy in 233
–ovarian tumor-related 473
–pancreatic cyst 185
–pyogenic see pyogenic lesions
–splenic cysts 215
–splenic enlargement 208, 209
–urinary tract obstruction complicated by 392
–see also abscess; bacteria; parasites infiltration, fatty
–liver 73, 74–75, 80–81
–– diffuse 75
–– focal 80–81
–pancreas 191
infiltration, tumorous see invasion inflammatory adnexal mass, ovarian 465 inflammatory atrophy of gallbladder 151
– see also cholecystitis
inflammatory bowel disease 283–285 inflammatory lymph node see lymph node
enlargement
inflammatory pleural effusions 524, 528 inflammatory pseudotumor 253 inflammatory tumor, renal 356 inguinal hernia 257, 281, 289
injuries (traumatic)
–gallbladder wall thickening following 152
–hepatic 119
–– capsular 90
–renal 358, 392
–splenic 222
–– cystic lesion 214
insufficiency, venous 33 insulinoma 182 interferon-induced thyroiditis 489 interlobar arteries 321, 361
– crossing 328
558
international classification of acute pancreatitis 174
interstitial pneumonia 547 intestine (bowel) 274–291, 317–318
–anatomy and topography 261–262
–disruption or impairment of propulsion, transport 288, 316
–fluid-filled loops 28, 265
–gut signature and 263
–hepatic metastases 96, 113
–herniation 257, 281, 289, 436
–large see large intestine
–small see small intestine
intima, aortic 3
– dissection 25
intracavitary lesions and masses
–bladder 402–409
–uterus 451–453
intraductal papillary mucinous (IPM) carcinoma 192, 194
intraductal papillary mucinous neoplasms (IPMNs) 192, 193, 194, 198
intrahepatic portal occlusion 44 intraluminal lesions/masses/changes
–arteries 22–25
–bile duct 140–141
–gallbladder 160–162
–polypoid see polypoid changes/lesions
–veins 34–36
–– portal 48–50
intraperitoneal... see peritoneal cavity intrauterine contraceptive device (IUD) 451,
453 intussusception 277
invasion and infiltration (tumorous)
–abdominal lymph node 239–240
–adrenal 371
–arterial (incl. aorta) 19
–chest wall, by lung tumor (Pancoast tumor) 517, 544
–pancreatic 171
–renal 342, 343
–seminal vesicles 427, 428
–splenic 215–217, 225
–thyroid 498
–venous 37–38
–– hepatoportal system 52, 68–69, 104, 105
–– vena cava 37–38
–see also metastases
invasive sclerosing thyroiditis 483 irritable bowel syndrome 287, 290 ischemia, intestinal 286, 291 ischemic nephropathy 335 isoechoicity
–gallbladder surrounding tissue 164
–kidney 350–356
–liver masses 101–107
–pancreas 186–188
–thyroid 499–500
J
jejunum
–anatomy and topography 261
–gallstones in 278
–lymphoma 276
–morphology 262
juveniles see children
K
kidneys 309, 319–364, 392, 392–397
–acute failure 331, 337
–anatomy 321
–anomalies and malformations 322–323, 325–329, 383
–circumscribed changes 344–363
–complex echo structure 356–358
–cortex 321
–– cysts 346
–– nephrocalcinosis 362
–cysts see cysts
–diffuse changes 329–343
–horseshoe 28, 327
–hypoechoicity 337, 350–356, 392–393
–large 329–334
–medulla 321
–– cystic degeneration 348
–– nephrocalcinosis (and medullary sponge kidney) 324, 362
–parenchyma
–– in chronic vs. acute disease 338
–– hepatic parenchyma compared with 70
–– hypoechoic transformation 338
–– notching 360
–small 334–336
–topography 322
kinking, aortic 6
Klatskin cholangiocellular carcinoma 50, 131, 133, 137, 137
L
laboratory studies
–adrenal incidentaloma 373
–peritoneal fluid 299
–thyroid
–– Graves hyperthyroidism 481
–– medullary carcinoma 496
–– nodules 492
laparoscopy
–focal liver lesions 120
–ovarian tumor 473 large intestine 274–291
–dilatation 287
–obstruction (nonvascular) 318
–peristalsis 263
–see also colon
legs, lymph nodes draining the 245–247 leiomyoma
–stomach wall 267
–uterine (fibroids; myoma) 447, 448–449, 450
–vena cava 48
ligaments gastrosplenic 204
–round, of liver (ligamentum teres) 114
–splenorenal 204
light chain deposition disease 342 limb (extremity) lymph nodes 245–247 Lindsay tumor 496, 497
lipid cell tumor, ovarian 471 lipoma
–adrenal 375
–bladder 407
–cutaneous 515
–hepatic 94, 100
–thyroid 494
–see also angiomyolipoma; fibrolipomatosis; hemangiomyolipoma; myelolipoma
lipomatosis
–pancreatic 175
–renal sinus 355, 395
–see also fibrolipomatosis liposarcoma
–cutaneous metastases 516
–uterine 450
liquefaction
–pulmonary 535
–– in pneumonia 548, 549, 550
–splenic
–– infarct 219
–– with metastases 224
lithium-induced thyroiditis 485, 488 liver 55–123, 309
–anatomy 58
–– normal variants 59, 60
–atrophy 76
–block before (prehepatic) 44
–caudate lobe see caudate lobe
–cirrhosis see cirrhosis
–congestion 71–72, 143
–– acute 71, 78
–– chronic 68, 71–72
–diffuse change 66, 70–86, 117, 118
–enlargement see hepatomegaly; hepatosplenomegaly
–fibrosis 42, 79
–focal/localized change see focal change
–function 57
–gallbladder wall thickening relating to 152
–liver obstruction relating to 134
–lymph nodes 63, 247–248
–morphology (sonographic) and its assessment 59–69
–– dynamic criteria 63
–– extrinsic criteria 60, 63
–– intrinsic criteria 60, 62, 63
–– supplementary criteria 63
–necrosis 81, 113
–portal occlusion relating to 47–48
–resection 77
–shunts 45, 95
–size determination 71, 123
–small 76–77
–topography 57
lobar pneumonia 547, 548, 550 lob(ul)ation, fetal (kidney) 328 localized change see focal change lumen
–blood vessel, diameter
–– aorta 3
–– inferior vena cava 4
–– portal vein, enlarged 41
–dilatation see dilatation
–gastrointestinal tract
–– fluid within, differentiation from extraluminal fluid 316–318
–– gut signature and 262, 263
–lesions within see intraluminal lesions
–narrowing or blockage see obstruction; occlusion; stenosis
–wall see wall
lung 531–551
–masses 533–551
–– anechoic 534–536
–– complex 546–550
–– cyst 519, 535
–– hypoechoic 537–546
–topography and morphology 533
Index
559
Index
lung cancer (carcinomas incl. bronchial carci- |
– thyroid |
|
495 |
– – irregular 117–119 |
|
|
|||||||
noma) 536, 538, 544–546 |
|
– uterine |
|
447 |
– nodular see nodules |
|
|
||||||
– adrenal metastases 370, 371, 372, 374, 376 |
– see also Hodgkin disease |
– ovarian adnexal see adnexal lesions/masses |
|||||||||||
– apex of lung/chest wall involvement (Pan- |
lymphoproliferative disorders, splenic infarc- |
– pancreatic duct see pancreatic duct |
|||||||||||
coast tumor) |
517, 544 |
|
tion 217 |
– periampullary see periampullary lesions and |
|||||||||
– atelectasis in |
539, 540 |
|
|
|
|
masses |
|
|
|
|
|
||
– cutaneous metastases 516 |
|
M |
|
|
– perirenal see perirenal lesions |
||||||||
– hepatic metastases 96 |
|
|
|
– peritoneal tumor 316 |
|
|
|||||||
– interstitial pneumonia and 547 |
|
|
|
|
– perivascular see perivascular lesions and |
||||||||
– lobar pneumonia and 550 |
|
macrofollicular thyroid adenoma or nodule |
masses |
|
|
|
|
|
|||||
– pleural effusions 525, 527, 535 |
|
501 |
|
|
– pleural 518–520 |
|
|
||||||
lutein cyst 462 |
|
|
macroglobulinemia, Waldenström 342 |
– pulmonary see lung |
|
|
|||||||
lymph cysts |
|
|
|
magnetic resonance imaging (MRI), focal liver |
– renal pelvic 394–398 |
|
|
||||||
– parapelvic/peripelvic 346 |
|
lesions |
120 |
– scrotal 435–436 |
|
|
|||||||
– thyroid |
489, 490 |
|
malabsorption, gallbladder changes 151 |
– ureteral see ureter |
|
|
|||||||
lymph flow parameters 238 |
|
malacia, myoma 448 |
– vaginal 442–443 |
|
|
||||||||
lymph node(s) |
231–258 |
|
male genital tract 416–437 |
– vascular intraluminal see intraluminal lesions |
|||||||||
– abdominal see peritoneal cavity |
|
malignant tumors (cancer) |
– vascularization of see vascularization |
||||||||||
– anatomy 233 |
|
– adrenal |
|
371–372, 375, 377 |
– see also diffuse or general changes; focal |
||||||||
– morphology 235–241 |
|
– biliary 131, 134, 137 |
change |
|
|
|
|
|
|||||
– peripheral see peripheral lymph nodes |
|
– – gallbladder 118, 157, 159 |
mechanical ileus |
288 |
|
|
|||||||
– topography |
233–234 |
|
– – periampullary 140, 197 |
media |
|
|
|
|
|
||||
lymph node enlargement/inflammation and |
– bladder |
|
404–405, 407, 412 |
– aortic 3 |
|
|
|
|
|
||||
lymphadenopathy 233 |
|
– breast see breast cancer |
– calcific stenosis |
22 |
|
|
|||||||
– axilla and groin 245 |
|
– chest wall 517 |
median arcuate ligament syndrome 13 |
||||||||||
– biliary, cholestasis due to 135 |
|
– gastrointestinal tract |
mediastinal lymph nodes |
257 |
|||||||||
– head/neck |
242 |
|
– – esophagus see esophagus |
medullary sponge kidney |
324, 362 |
||||||||
– mesenteric |
252, 282 |
|
– – gastric see stomach |
medullary thyroid carcinoma 496 |
|||||||||
– pancreatic |
184 |
|
– – intestine 275–276 |
megacalicosis 385 |
|
|
|||||||
– porta hepatis |
247 |
|
– – lymph node metastases 241 |
megaureter |
385 |
|
|
|
|||||
– retroperitoneal (para-aortic; iliac etc.) |
254 |
– genital tract of females |
melanoma (malignant) |
|
|
||||||||
– splenic hilum |
249 |
|
– – cervix |
|
457–458 |
– lymph node metastases |
249, 255 |
||||||
– venous compression caused by 38 |
|
– – fallopian tubes 459 |
– thyroid metastases 498 |
||||||||||
lymph node metastases |
|
– – ovary see ovaries |
Ménétrier disease |
271 |
|
|
|||||||
– axilla/groin |
246 |
|
– – signs of malignity 474 |
menopause |
441 |
|
|
|
|||||
– head/neck |
242 |
|
– – uterus |
450, 456–458 |
– ovaries before 474 |
|
|
||||||
– mesenteric |
252 |
|
– – vagina |
443 |
– see also postmenopause |
|
|||||||
– ovarian cancer 466, 467, 468 |
|
– genital tract of males |
menstrual cycle 454–455 |
|
|||||||||
– porta hepatis |
248 |
|
– – prostate 405, 419–420, 421, 425 |
mesenchymal tumors |
|
|
|||||||
– prostatic cancer 419 |
|
– – testes see testicles |
– bladder 405 |
|
|
|
|
||||||
– retroperitoneal (para-aortic; iliac etc.) |
255 |
– hematological, splenomegaly 210 |
– kidney, mixed with epithelial tumor 352 |
||||||||||
– splenic hilum |
250 |
|
– hepatic |
|
68, 86, 99–100, 103–105, 112–113, |
mesenteric artery |
|
|
|
||||
– see also TNM staging |
|
118, 121 |
|
|
– stenosis 14 |
|
|
|
|
||||
lymphangioma, small bowel 276 |
|
– lung see lung cancer |
– superior, pancreas and |
|
169 |
||||||||
lymphatic system |
|
– lymphadenopathy caused by 233 |
mesenteric lymph nodes |
|
251–254, 282 |
||||||||
– hepatic |
62 |
|
|
|
– pancreas see pancreas |
mesenteric veins |
39 |
|
|
||||
– pancreatic |
170 |
|
– perivascular/vascular disturbances 27, 68 |
– superior |
39 |
|
|
|
|
||||
lymphocele, perirenal 346 |
|
– – arterial stenosis due to 19 |
– – pancreas and |
169 |
|
|
|||||||
lymphocytic lymphoma, porta hepatis lymph |
– – venous infiltration due to 38 |
– – thrombosis |
51 |
|
|
||||||||
node metastases 249 |
|
– pleural |
519, 521, 523 |
mesothelioma, malignant |
519, 523 |
||||||||
lymphocytic thyroiditis see Hashimoto |
|
– pleural effusion with 524, 525, 526, 528 |
metabolic disorders, renal disorders in 341 |
||||||||||
lymphoma (malignant) |
|
– primary tumor sources |
metastases, distant |
|
|
||||||||
– adrenal |
371 |
|
|
– – hepatic metastases 97 |
– location |
|
|
|
|
|
|||
– arterial stenosis due to 19 |
|
– – peritoneal carcinomatosis 314 |
– – adrenal |
370, 371, 374, 376 |
|||||||||
– cutaneous |
516 |
|
– renal 257, 334, 352–356, 359 |
– – bladder |
405 |
|
|
|
|||||
– gastric |
268, 270, 271 |
|
– renal pelvis/ureter 394 |
– – cutaneous |
515 |
|
|
||||||
– hepatic |
86, 94, 97 |
|
– splenic |
206, 215–217, 227 |
– – gallbladder |
160 |
|
|
|||||
– intestinal 276, 287 |
|
– splenic enlargement in malignant systemic |
– – hepatic 85, 95, 96–97, 106, 113, 118, 121, 143 |
||||||||||
– lymph node involvement 240 |
|
disease |
|
208 |
– – ovaries |
467, 468 |
|
|
|||||
– – axilla/groin |
246 |
|
– spread see infiltration; metastases |
– – pancreatic |
139, 183, 184, 199 |
||||||||
– – head/neck |
243–244 |
|
– staging of see staging |
– – perivascular arterial |
27 |
||||||||
– – mesenteric |
252 |
|
– thyroid |
|
495–498, 504 |
– – perivascular venous |
38 |
||||||
– – porta hepatis 248, 249 |
|
– see also specific types |
– – pleural |
518 |
|
|
524, 527 |
||||||
– – retroperitoneal (para-aortic; iliac etc.) 255 |
malrotation of kidney 326 |
– – pleural effusions with |
|||||||||||
– – splenic hilum 250 |
|
Marfan syndrome 7, 9 |
– – pulmonary |
544–546 |
|
|
|||||||
– pancreatic |
171, 184, 199 |
|
Marine–Lenhart syndrome 482, 504 |
– – renal 350, 356 |
|
|
|||||||
– perivascular 27 |
|
masses |
|
|
– – rib/sternal |
514 |
|
|
|||||
– – arterial stenosis due to 19 |
|
– bile duct see bile duct |
– – splenic |
206, 224–225 |
|
||||||||
– pleural |
521, 525 |
|
– bladder, intracavitary 402–409 |
– – thyroid |
498 |
|
|
|
|||||
– pulmonary |
545 |
|
– chest wall see chest wall |
– source (= primary tumor) |
|||||||||
– renal 342, 354, 357 |
|
– cystic see cyst |
– – from bladder |
404 |
|
|
|||||||
– splenic |
210, 215–217, 227, 250 |
|
– hepatic |
|
86–122 |
– – of hepatic metastases |
97 |
560
– – from lung see lung cancer |
nephroblastoma |
354 |
|
– – metastatic pleural effusions 527 |
|||||||
– – from prostate |
405, 419 |
nephrocalcinosis |
362 |
|
– morphology |
460 |
|||||
– – from stomach |
113, 122, 301 |
– cortical 362 |
|
|
|
– topography |
460 |
||||
– – see also invasion; TNM staging |
– medullary (and medullary sponge kidney) |
overflow bladder 399 |
|||||||||
metastases, lymph node see lymph node me- |
324, 362 |
|
|
|
|
|
|
|
|||
tastases |
|
|
|
nephronophthisis, familial 324 |
P |
|
|
|
|||
microabscess, splenic |
220, 221 |
neuroblastoma |
377 |
|
|
|
|
||||
microcalcification |
|
|
neuroendocrine tumors see endocrine and |
|
|
|
|
||||
– chronic pancreatitis |
190 |
neuroendocrine tumors |
|
pain and gut signature 263 |
|||||||
– thyroid carcinoma 496 |
neurogenic bladder 399 |
|
pampiniform venous plexus varices (= varico- |
||||||||
microfollicular adenoma 491–492 |
newborns, hypothyroidism |
485 |
cele) 436 |
|
|
||||||
microlithiasis |
|
|
nodular hypersplenism 227 |
|
panarteritis nodosa 21 |
||||||
– biliary (small gallstones) 135, 157, 160, 161 |
nodules (and nodular masses) |
Pancoast tumor 517, 544 |
|||||||||
– testicular 433 |
|
|
– liver |
|
|
|
pancreas |
167–200, 198–199, 309 |
|||
Mirizzi syndrome |
135, 154 |
– – focal nodular hyperplasia (FNH) 86, 99, |
– anatomy 169 |
||||||||
miscarriage (abortion), missed or incomplete |
101–103, 101, 112, 121 |
|
– annular |
188 |
|||||||
453 |
|
|
|
– – regenerative nodule (liver) 86, 112 |
– biliary dilatation/obstruction relating to |
||||||
Mönckeberg’s arteriosclerosis 22 |
– pleural 518–520 |
|
138–139 |
|
|
||||||
mononucleosis 207, 209, 248 |
– pulmonary, peripheral 535 |
– cancer |
183–184, 186–187, 192, 193, 197 |
||||||||
MRI (magnetic resonance imaging), focal liver |
– thyroid 492 |
|
|
|
– – carcinoma see carcinoma; cystadenocarci- |
||||||
lesions |
120 |
|
|
– – adenomatous see adenomatous thyroid |
noma |
|
|
|
|||
mucinous biliary papillomatosis 131 |
nodules |
|
|
|
– – focal pancreatitis vs. 186 |
||||||
mucinous cystic neoplasms |
– – autonomous |
482, 492, 503 |
– diffuse change 170–178, 195 |
||||||||
– ovaries |
463, 470 |
|
– – cold 492, 496, 498, 501 |
|
– divided (pancreas divisum) 187, 196, 199 |
||||||
– pancreas 192, 193, 194 |
– – cystic masses with 489, 490 |
– exocrine vs. endocrine functions 169 |
|||||||||
mucinous peritoneal carcinomatosis 307 |
– – macrofollicular 501 |
|
– gallbladder wall thickening relating to 152 |
||||||||
mucocele |
|
|
|
– – malignant vs. benign 496–497, 497 |
– hepatic parenchyma compared with 70 |
||||||
– appendiceal 276 |
|
– – multiple 496, 503 |
|
– large/enlarged 170–171, 195 |
|||||||
– uterine |
452 |
|
|
– – normofollicular 499 |
|
– pseudocysts |
179, 180, 185, 192, 251, 369 |
||||
mucosal folds, gastric |
269 |
– – regressive change 500, 501 |
– small/reduced 172–173, 195 |
||||||||
müllerian duct fusion anomalies 443, 446 |
non-Hodgkin lymphoma see lymphoma |
– topography 169 |
|||||||||
multiple cysts |
|
|
normofollicular thyroid adenoma 491, 499 |
– tumors see tumors |
|||||||
– kidney |
325, 344 |
|
|
|
|
|
pancreatectomy 173 |
||||
– ovaries |
462 |
|
|
O |
|
|
|
pancreatic duct (Wirsung’s duct) 169, 181 |
|||
– thyroid |
490 |
|
|
|
|
|
– accessory |
169 |
|||
multiple endocrine neoplasia (MEN) syndrome |
|
|
|
|
– dilatation |
195–199 |
|||||
496 |
|
|
|
obstruction (nonvascular) |
|
– gas 190 |
|
|
|||
multiple thyroid nodules 496, 503 |
– biliary 132–140 |
|
– lesions/masses within 198 |
||||||||
myelolipoma, adrenal |
375 |
– – location in differential diagnosis of choles- |
– – carcinoma |
139, 183, 184 |
|||||||
myeloproliferative disorders, splenic 227 |
tasis 142 |
|
|
|
– – cysts |
181 |
|
||||
– infarction 217 |
|
|
– bronchial, causing atelectasis 537 |
– – see also intraductal papillary mucinous |
|||||||
– splenomegaly 210 |
|
– gastric outlet |
272, 317 |
|
carcinoma; intraductal papillary mucinous |
||||||
myolipoma, thyroid 502 |
– large-bowel |
318 |
|
neoplasms |
|||||||
myoma |
|
|
|
– pancreatic, in chronic pancreatitis 178 |
– stent 190 |
170–171, 174–175, 176–178, 195, |
|||||
– bladder |
407 |
|
|
– renal pelvic, by uterine myoma 449 |
pancreatitis |
||||||
– thyroid |
502 |
|
|
– small-bowel |
317 |
|
196–197, 197–198, 303, 313 |
||||
– uterine |
447, 448–449, 450 |
– urinary tract |
385, 390, 392 |
– acute 51, 170–171, 174, 196 |
|||||||
myometrial changes 446–450 |
– see also occlusion; stenosis; stricture |
– – Atlanta classification 174, 181 |
|||||||||
myxedema 480, 484 |
|
occlusion, vascular (obstruction; complete |
– – relapsing |
181, 197 |
|||||||
|
|
|
|
block) |
|
|
|
– autoimmune 175 |
|||
N |
|
|
|
– arterial (incl. aortic) 17 |
|
– chronic |
138, 171, 176–178, 191, 197, 197–198 |
||||
|
|
|
– – splenic 217 |
211 |
|
– – atrophic |
172, 200 |
||||
|
|
|
|
– asplenia due to |
|
– – calcifying |
177, 189 |
||||
neck nodes see head and neck |
– portal |
|
|
|
– – cancer risk 199 |
||||||
necrosis |
|
|
|
– – intrahepatic |
45–47 |
|
– – early |
174 |
|
||
– hepatic |
81, 113 |
|
|
– – posthepatic 47–48 |
|
– – focal |
191 |
|
|||
– pancreatic 179, 181 |
|
– – prehepatic |
44 |
|
– – recurrent |
174, 196 |
|||||
– – focal, in chronic pancreatitis 178 |
– see also obstruction; stenosis; stricture |
– focal (segmental) 185, 187 |
|||||||||
– – infected or sterile peripancreatic necrosis |
oncocytoma (oncocytic adenoma) |
– gastric wall in 271 |
|||||||||
171 |
|
|
|
– renal 352, 356 |
|
|
– necrotizing |
173, 311 |
|||
– – peripancreatic fat necrosis 171, 190 |
– thyroid 493 |
|
|
|
– – hemorrhagic 181 |
||||||
– – post-pancreatitic see pancreatitis |
orchitis 430 |
|
|
|
– peritoneal fluid in 303, 313 |
||||||
– pulmonary 545 |
|
|
Ormond disease (retroperitoneal fibrosis) 28, |
papillae, renal |
|
||||||
– uterine myoma |
449 |
|
38, 391 |
|
|
|
– calcification |
361 |
|||
needle biopsy (percutaneous) |
Osler–Weber–Rendu syndrome 94 |
– necrosis 348 |
|||||||||
– fine see fine-needle aspiration |
ovaries 460–474 |
|
|
papillary adenoma |
|||||||
– liver lesions 120 |
|
– anatomy and histology 460 |
– kidney |
356 |
|
||||||
– lung tumors and metastases 544 |
– appendicitis vs. disorders of 280 |
– thyroid |
491–492 |
||||||||
neonatal hypothyroidism 485 |
– cancer 463, 465–469, 469, 470, 471, 472, 473 |
papillary biliary lesions 140 |
|||||||||
neoplasms see tumors |
|
– – clinical aspects 473 |
|
papillary carcinoma |
|||||||
nephritis, acute 337 |
|
– – diagnosis and treatment |
473 |
– biliary |
140 |
|
|||||
– see also glomerulonephritis; pyelonephritis |
– – lymph node metastases |
237, 250, 255 |
– bladder |
404 |
Index
561
Index
– renal cell 352 |
|
|
– localized changes 308–312 |
|
portal circulation (in general) |
|
|||||||||
– thyroid 496, 497, 504 |
|
– lymph nodes 238–241, 247–251 |
|
– hypertension 41–47, 207, 209 |
|
||||||||||
papillary mucinous neoplasms, intraductal |
– – biliary |
63 |
|
|
|
|
– splenic enlargement relating to 208 |
|
|||||||
192, 193, 194, 198 |
|
|
– – hepatic |
63, 247–248 |
|
portal veins (and branches/tributaries) |
39–53 |
||||||||
papillomas |
|
|
– – pancreatic |
170 |
|
|
– anatomy 39, 62 |
|
|
||||||
– bladder 404, 407 |
|
|
– – regions |
234 |
|
|
|
– anechoic masses |
95 |
|
|||||
– gallbladder 158, 159 |
|
– – staging with tumors involving 241 |
– in cirrhosis |
83 |
|
|
|
||||||||
papillomatosis, mucinous biliary 131 |
– morphology |
296–297 |
|
– congenital hypoplasia 209 |
|
||||||||||
para-aortic region |
|
|
– pseudomyxoma 307, 469 |
|
– embolism 81, 117 |
|
|||||||||
– lymph nodes 254–257 |
|
– topography |
295 |
|
|
– flow patterns 62, 64 |
|
||||||||
– other structures 255 |
|
peritonitis (bacterial) 301, 314 |
|
– infiltration and invasion by tumor 52, 68–69, |
|||||||||||
paracaval lymph nodes 254–257 |
|
– purulent |
301, 303, 305, 314 |
|
104 |
|
|
|
|
|
|||||
paracentesis, fine-needle 298, 299 |
– spontaneous, cirrhosis of liver with |
303 |
– pathology 69 |
|
|
|
|||||||||
parafollicular cell (C-cell) carcinoma, medul- |
perivascular lesions and masses |
|
– thrombosis |
41, 48, 64, 100, 107, 143 |
|
||||||||||
lary thyroid 496 |
|
|
– arterial |
25–28 |
|
|
|
– topography |
39, 128 |
|
|||||
parailiac lymph node enlargement 255–256 |
– spleen |
217 |
|
|
|
|
positron emission tomography (PET), focal liver |
||||||||
paralytic ileus 288 |
|
|
– venous |
38 |
|
|
|
|
lesions |
120 |
|
|
|
|
|
paraovarian cyst 462 |
|
PET (positron emission tomography), focal liver |
posthepatic portal occlusion (complete block) |
||||||||||||
parapelvic lymph cysts 346 |
|
lesions |
120 |
|
|
|
|
47–48 |
|
|
|
|
|
||
paraprotein kidney |
333 |
|
pheochromocytoma 375, 376 |
|
postmenopause |
441 |
|
||||||||
parasites, bile duct |
141 |
|
phleboliths |
36 |
|
|
|
– endometrium |
454, 474 |
|
|||||
parathyroid gland |
|
|
phlegmonous cholecystitis 152, 153 |
|
postoperative status |
|
|||||||||
– adenoma 494, 500 |
|
placental polyps |
453 |
|
|
– bladder 402 |
|
|
|
||||||
– hyperplasia 477 |
|
|
plaque |
|
|
|
|
|
|
– cholecystectomy |
132, 163, 196 |
|
|||
– location 478 |
|
|
– arteriosclerotic |
19, 20–21 |
|
– gastrectomy |
274 |
|
|
||||||
parenchyma |
|
|
– – protruding 23 |
|
|
– pancreatectomy |
173 |
|
|||||||
– hepatic |
|
|
– pleural |
518, 520 |
|
|
– prostate (after prostatectomy or transureth- |
||||||||
– – cholestasis relating to 142 |
|
plasmacytoma, cutaneous metastases |
516 |
ral resection) 422, 424 |
|
||||||||||
– – diffuse change |
66, 70–86, 117, 118 |
pleura 511, 512, 518–529 |
|
– thyroid resection |
486 |
|
|||||||||
– – echotexture 60, 62 |
|
– anatomy and topography 511 |
|
– vagina |
444 |
|
|
|
|
||||||
– – localized change see focal change |
– effusions |
519, 523–529 |
|
postpartum period |
|
|
|||||||||
– pancreatic, in chronic pancreatitis 176 |
– – atelectasis caused by compression from |
– thyroiditis 487 |
|
|
|||||||||||
– renal see kidney |
|
|
537 |
|
|
|
|
|
|
– uterus |
445, 457 |
|
|
||
– splenic |
|
|
– – loculated |
523, 528, 534, 535 |
|
postprandial pancreatic duct dilatation |
196 |
||||||||
– – diffuse changes |
206–207 |
|
– morphology |
511 |
|
|
Potter syndrome |
|
|
|
|||||
– – focal lesions with lymphoma |
215 |
– parietal |
518–523 |
|
|
– type I |
324 |
|
|
|
|
||||
– – trauma 223 |
|
|
– plaque |
518, 520 |
|
|
– type II |
324 |
|
|
|
|
|||
– thyroid, diffuse goiter 479–480 |
|
– structural defects 541 |
|
– type III (autosomal dominant polycystic kid- |
|||||||||||
pediatrics see children |
|
– thickening 519, 520–523 |
|
ney disease) |
324, 325, 344 |
|
|||||||||
peliosis, hepatic 94 |
|
pleuritis (pleurisy) 549 |
|
pregnancy 452–455 |
|
||||||||||
percutaneous needle biopsy see needle biopsy |
– with effusions |
524 |
|
|
– laparoscopy, ovarian tumor 473 |
|
|||||||||
perforation |
|
|
pleuropneumonia 549 |
|
|
– ovarian tumor in |
473 |
|
|||||||
– gallbladder, with gallstones 154, 278 |
pneumobilia 140 |
|
|
|
– thyroid dysfunction in 487 |
|
|||||||||
– GI tract 312 |
|
|
pneumonia |
546–549 |
|
|
– see also postpartum period |
|
|||||||
– – appendix 281 |
|
|
– lobar 547, 548, 550 |
|
|
prehepatic block |
44 |
|
|||||||
– – duodenal ulcer |
305, 306, 308, 312 |
pneumoperitoneum (intra-abdominal gas col- |
premenopausal ovaries 474 |
|
|||||||||||
– – gastric ulcer 269 |
|
lections) |
296, 307 |
|
|
pressures in biliary system 132–140 |
|
||||||||
periadrenal masses |
369 |
|
pneumothorax 529 |
|
|
– in differential diagnosis of cholestasis |
142 |
||||||||
periampullary lesions and masses |
140 |
polycystic kidney disease 324–325, 331, 344 |
primary sclerosing cholangitis 130, 132, 142 |
||||||||||||
– malignant 140, 197, 199 |
|
– autosomal dominant (Potter syndrome type |
primary tumors |
|
|
|
|||||||||
peripelvic lymph cysts 346 |
|
III) 324, 325, 344 |
|
|
– location (as source of metastases) see me- |
||||||||||
peripheral arterial stenosis 16 |
|
– autosomal recessive |
324 |
|
tastases |
|
|
|
|
||||||
peripheral lymph nodes 241–247 |
|
polycystic liver disease |
89, 92, 309 |
|
– in TNM staging (= T) |
|
|||||||||
– topography 233–234 |
|
polycystic ovary syndrome 462 |
|
– – bladder carcinoma 412 |
|
||||||||||
peripheral vein anomalies 30 |
|
polyglandular autoimmune syndrome |
483, |
– – ovarian cancer |
466, 468 |
|
|||||||||
perirenal lesions 350 |
|
484 |
|
|
|
|
|
|
– – prostatic carcinoma 419 |
|
|||||
– cystic 345 |
|
|
polyp(s) |
|
|
|
|
|
|
– uterine corpus |
456 |
|
|||
peristalsis 263 |
262, 263 |
|
– cervical |
453 |
|
|
|
prolapsed uterus |
446 |
|
|||||
– gut signature and |
|
– endometrial |
453 |
|
|
proliferative phase of menstrual cycle 454 |
|||||||||
– ileus and 288 |
|
|
– gastric |
266 |
|
|
|
|
prostate |
417–426 |
|
|
|||
– intestinal fluid-filled loops and |
28, 265 |
– intestinal |
276 |
|
|
|
– anatomy and topography 417 |
|
|||||||
peritoneal cavity (and abdominal cavity) |
– placental |
453 |
|
|
|
– changes and lesions 417, 418–422 |
|
||||||||
293–318 |
|
|
polypoid changes/lesions (intraluminal) |
– – benign hyperplasia see hyperplasia |
|
||||||||||
– anatomy 295 |
|
|
– bladder |
404–405, 407 |
|
– – carcinoma see carcinoma |
|
||||||||
– blood (hematoperitoneum) 222 |
– gallbladder |
156, 159, 162 |
|
– – enlarged size 418–422 |
|
||||||||||
– carcinomatosis see carcinomatosis |
– intestine |
276, 290 |
|
|
– – reduced size |
422–426 |
|
||||||||
– diffuse changes 298–308 |
|
– stomach |
266 |
|
|
|
prostate-specific antigen (PSA) assay 419 |
||||||||
– fluid collections exterior to 296, 308, |
porcelain gallbladder 155 |
|
prostatitis |
|
|
|
|
||||||||
316–316 |
|
|
porphyria 112 |
|
|
|
– acute 420–421 |
|
|
||||||
– fluid collections within see fluid collections |
porta hepatis |
57, 128, 129 |
|
– chronic 422, 423 |
|
||||||||||
– hernia 257, 281, 289, 436 |
|
– lymph nodes 247–248 |
|
pseudoaneurysms |
8, 11, 25 |
|
|||||||||
|
|
|
|
|
|
|
|
|
|
– splenic |
214, 219 |
|
|
562
pseudoascites (extraperitoneal/extra-abdomi- |
renal cell carcinoma |
334, 352, 357 |
|
septic pyelonephritis 333 |
||||||||||||
nal fluid collections) 296, 308, 316–316 |
– adrenal metastases |
374 |
|
|
septic–toxic kidney |
332, 341 |
||||||||||
pseudocysts |
179, 180, 185, 192, 251, 369 |
– cystic 347, 352, 357 |
|
|
seroma, renal |
349 |
|
|||||||||
– pancreatic |
renal pelvis |
386–392 |
|
|
serometra 452 |
|
|
|||||||||
– splenic 214 |
|
|
|
– abscess |
393 |
|
|
|
seropneumothorax |
529 |
||||||
– see also lymphocele |
|
– anatomy 381 |
|
|
|
serous cystic neoplasms |
||||||||||
pseudodiverticula |
|
|
– ectasia (pyelectasis) 349, 364, 386 |
|
– ovary 463, 469, 470 |
|||||||||||
– bladder 401, 411, 413–414 |
– inflammation see pyelitis; pyelonephritis |
– pancreas |
192, 193, 194 |
|||||||||||||
– sigmoid colon |
279 |
|
– mass 394–398 |
|
|
|
Sertoli stromal cell tumors 471 |
|||||||||
pseudomembranous enterocolitis 286 |
– stone see urolithiasis |
|
|
sex cord-stromal tumors 469, |
||||||||||||
pseudomyxoma peritonei 307, 469 |
– uterine myoma causing obstruction |
449 |
sex hormones |
441, 460 |
||||||||||||
pseudopapillary neoplasms, solid 193, 194 |
renal veins 321 |
|
|
|
shock, renal 331 |
|
|
|||||||||
pseudopolyps, cholesterol 158, 159 |
– anomalies |
30 |
|
|
|
– hypoxemic |
338 |
|
||||||||
pseudotumor |
|
|
|
– ectasia |
349 |
|
|
|
shunts, intrahepatic |
45, 95 |
||||||
– fibrous 436 |
|
|
|
– thrombosis 332, 337 |
|
|
sickle-cell anemia 211, 217 |
|||||||||
– inflammatory |
253 |
|
renovascular malformations 329 |
|
side-lobe artifact (bladder) 408 |
|||||||||||
psoas muscle, hepatic parenchyma compared |
reproductive tract see genital tract |
|
sigmoid colon |
|
|
|
||||||||||
with 70 |
|
|
|
|
retention cyst |
|
|
|
– diverticula 278 |
|
|
|||||
pulmonary parenchyma/non-vascular tissue |
– ovarian |
461 |
|
|
|
– – inflammation (diverticulitis) 279 |
||||||||||
see lung |
|
|
|
|
– pancreatic |
179, 180 |
|
|
– pseudodiverticula |
279 |
||||||
pulmonary vessels |
548 |
|
– renal 345 |
|
|
|
|
single kidney |
330 |
|
||||||
– embolism |
538–544 |
|
reticuloendothelial tumors of bladder |
405 |
sinus, renal, masses |
354, 395, 397 |
||||||||||
pulsatility index and peripheral arterial steno- |
retroperitoneal branches |
|
|
situs inversus |
5 |
|
|
|||||||||
sis 16 |
|
|
|
|
– abdominal aorta 3 |
|
|
|
skin metastases 515 |
|||||||
pulseless disease (Takayasu arteritis) 15, 21 |
– inferior vena cava |
4 |
|
|
sludge |
|
|
|
|
|
||||||
purulent lesions see pyogenic lesions |
retroperitoneum/retroperitoneal space |
|
– bladder 404 |
|
|
|||||||||||
putty kidney |
363 |
|
|
254–257, 296 |
|
|
|
– gallbladder |
161–162, 166 |
|||||||
pyelectasis 349, 364, 386 |
|
– fibrosis |
28, 38, 391 |
|
|
small cell lung cancer, hepatic metastases 96 |
||||||||||
pyelitis (and pyelonephritis), suppurative 343, |
– lymph nodes 254–257 |
|
|
small intestine 274–291 |
||||||||||||
393 |
|
|
|
|
– – regions 234 |
|
|
|
– anatomy and topography 261 |
|||||||
pyelocaliceal stone see urolithiasis |
– other structures 255 |
|
|
– dilatation |
287 |
|
|
|||||||||
pyelonephritis |
|
|
|
ribs 511, 512 |
|
|
|
|
– obstruction |
317 |
|
|||||
– acute 333 |
|
|
|
|
– fractures 513 |
|
|
|
– peristalsis |
263 |
|
|
||||
– chronic 335, 340 |
|
|
– metastases |
514 |
|
|
|
– see also entries under enter- |
||||||||
– emphysematous |
350, 362 |
Riedel goiter |
483 |
|
|
|
spermatocele |
434 |
|
|||||||
– suppurative 343, 393 |
|
Riedel lobe 59, 60 |
|
|
|
spherocytosis |
208 |
|
||||||||
– xanthomatous |
350, 357 |
|
Rokitansky–Küstner syndrome |
447 |
|
spindle cell renal carcinoma 352 |
||||||||||
pyloric stenosis |
264 |
|
round ligament of liver 114 |
|
|
splanchnic branches |
||||||||||
– hypertrophic 270 |
|
|
|
|
|
|
|
– abdominal aorta (incl. splanchnic arteries) 3 |
||||||||
pyogenic (purulent/suppurative) lesions |
S |
|
|
|
|
|
– – stenosis |
13 |
|
|
||||||
– cholangitis |
130 |
|
|
|
|
|
|
|
– inferior vena cava |
4 |
||||||
– fallopian tubes (pyosalpinx) 459 |
|
|
|
|
|
|
spleen 201–229, 309 |
|||||||||
– kidney |
|
|
|
|
sactosalpinx |
459 |
|
|
|
– accessory |
250, 372, 374 |
|||||
– – renal collecting system (pyonephrosis) |
Santorini’s duct 169 |
|
|
|
– anatomy |
203 |
|
|
||||||||
333, 343, 356, 393 |
|
saphenous insufficiency, greater 33 |
|
– focal changes 213–229 |
||||||||||||
– – renal pelvis (pyelonephritis) 343, 393 |
sarcoma |
|
|
|
|
|
– hepatic parenchyma compared with 70 |
|||||||||
– peritonitis |
301, 303, 305, 314 |
– cutaneous metastases 156 |
|
|
– hilar lymph nodes |
249–251 |
||||||||||
– pleura (pyothorax) 522, 550 |
– ovarian |
471 |
|
|
|
– infarction |
214, 217–220 |
|||||||||
– pleural effusions |
524 |
|
– uterine |
450 |
|
|
|
– large 208–210 |
|
|
||||||
– seminal vesicles |
427 |
|
scars, renal 350 |
|
|
|
– lymphoma |
210, 215–217, 227, 250 |
||||||||
– uterus (pyometra) 452 |
|
scintigraphy (radionuclide scan) |
|
– non-focal changes |
206–212 |
|||||||||||
– – myoma 448 |
|
|
|
– liver, focal lesions 120 |
|
|
– small 211–212 |
|
|
|||||||
|
|
|
|
|
– thyroid |
477 |
|
|
|
– topography |
204 |
|
||||
R |
|
|
|
|
– – carcinoma 496 |
|
|
|
splenic artery |
6, 170, 205 |
||||||
|
|
|
|
– – de Quervain thyroiditis 495 |
|
– aneurysms |
181 |
|
|
|||||||
radiation therapy |
|
|
– – in hyperthyroidism 505–506 |
|
– calcified 190 |
|
|
|||||||||
|
|
– – macrofollicular adenoma 501 |
|
– obstruction |
217 |
|
||||||||||
– hypothyroidism following |
485, 489 |
– – nodules |
483, 492, 498, 501, 504 |
|
– partial dearterialization 217 |
|||||||||||
– prostate following 423 |
|
– – normofollicular adenomas |
499 |
|
splenic vein |
39, 170, 203, 205 |
||||||||||
radioiodine-treated thyroid |
486 |
scirrhous carcinoma |
270, 274 |
|
|
– thrombosis |
50, 209 |
|||||||||
radionuclide imaging see scintigraphy |
sclerosing cholangitis, primary |
130, 132, 142 |
splenorenal ligaments 204 |
|||||||||||||
regenerative nodule (liver) |
86, 112 |
sclerosing thyroiditis, invasive |
483 |
|
splenorenal shunts |
45 |
||||||||||
regionally inhomogeneous liver texture 80–81 |
scrotal mass |
435–436 |
|
|
sprue (celiac disease) 265, 283 |
|||||||||||
renal... see entries below and kidney |
secretory phase of menstrual cycle 454 |
squamous cell carcinoma |
||||||||||||||
renal arteries 321 |
|
|
segmental anatomy of liver 58 |
|
|
– bladder 407 |
|
|
||||||||
– aneurysm |
349 |
|
|
– variants 59 |
|
|
|
– cervix |
457 |
|
|
|
||||
– arteriolosclerosis |
335 |
|
seminal vesicles 417, 426–428 |
|
|
– thyroid |
496, 497 |
|
||||||||
– arteriovenous malformations 349 |
seminoma 433 |
|
|
|
– uterine corpus |
456 |
||||||||||
– duplicated |
6 |
|
|
|
septation |
|
|
|
|
|
– vagina |
443 |
|
|
|
|
– embolism |
334–335 |
|
– ascites |
310 |
|
|
|
staghorn calculus |
363, 392, 396 |
|||||||
– stenosis 13, 334–335 |
|
– renal cyst |
344–345 |
|
|
staging of tumors |
|
|
||||||||
|
|
|
|
|
– vagina |
443 |
|
|
|
– bladder carcinoma 412 |
Index
563
Index
– in lymph node involvement 241, 257 |
|
testicles 429–439 |
|
|
|
|
TSH see thyroid-stimulating hormone |
||||||||||
– ovarian cancer 466, 468 |
|
– anatomy/topography 429 |
|
|
tuberculosis |
|
|
|
|||||||||
– prostatic carcinoma 412 |
|
– cancer 432 |
|
|
|
|
|
– lymphadenopathy 239, 254 |
|||||||||
– uterine corpus 456 |
|
– – lymph node metastases 239, 255 |
|
– peritoneal |
305 |
|
|
||||||||||
starvation gut |
290, 291 |
|
– changes |
417, 429–437 |
|
|
|
– pleural |
522 |
|
|
||||||
steatohepatitis (fatty liver hepatitis) 73–74 |
tetraiodothyronine (T4) 477 |
|
|
– prostatic 423 |
|
|
|||||||||||
steatosis see fatty change |
|
theca-lutein cyst |
462 |
|
|
|
|
– renal |
348, 363 |
|
|
||||||
Stein–Leventhal syndrome 462 |
|
thecoma and thecomatosis 464, 471 |
|
tuberous sclerosis 359 |
|
||||||||||||
stenosis (luminal narrowing) |
|
thoracic aortic aneurysm |
7, 9, 536 |
|
tumor/neoplasm |
|
|
||||||||||
– aortic see aorta |
|
thoracic wall see chest wall |
|
|
– adrenal |
371–373, 374–375, 376–377 |
|||||||||||
– arterial 12–19 |
|
thorotrast and thorotrastosis 118, 207 |
|
– arterial stenosis due to 19, 121 |
|||||||||||||
– – arteriosclerotic see arteriosclerosis |
|
thromboembolism, splenic infarction 217 |
|
– gallbladder 156–160 |
|
||||||||||||
– – renal 13, 334–335 |
|
thrombophilia, splenic infarction 217 |
|
– gastric |
266–268, 270–271, 274 |
||||||||||||
– biliary tree |
135 |
|
thrombosis (and thrombus) |
|
|
– hepatic |
85, 98, 99–100, 103–105, 112–113, |
||||||||||
– gastrointestinal tract |
|
– venous |
34–36 |
|
|
|
|
|
118 |
|
|
|
|
|
|||
– – duodenum |
317 |
|
– – hepatic 100 |
|
|
|
|
|
– intestinal |
275–276, 287, 290 |
|||||||
– – gastric pylorus see pyloric stenosis |
|
– – portal |
41, 48, 64, 100, 107, 143 |
|
– – stenosis |
290 |
|
|
|||||||||
– – gut signature and 263 |
|
– – renal |
332, 337 |
|
|
|
|
– invasion by see invasion |
|||||||||
– – intestine |
290–291 |
|
– – splenic 50, 209 |
|
|
|
|
– malignant see malignant tumors |
|||||||||
– pancreatic, benign causes 138 |
|
– – superior mesenteric |
51 |
|
|
– ovarian |
469–473 |
|
|||||||||
– urinary tract |
|
|
– – vena cava 32 |
|
|
|
|
– – clinical aspects 473 |
|||||||||
– – ureter (subpelvic) 387 |
|
– white arterial |
21, 23 |
|
|
|
– – cystic |
463, 470 |
|
||||||||
– – uteropelvic junction 385 |
|
thyroid arteries |
477, 478 |
|
|
|
– – diagnosis and treatment 473 |
||||||||||
– vena cava, dilatation due to 32 |
|
thyroid gland 475–507 |
|
|
|
– pancreatic |
161, 182–184, 186–187, 369 |
||||||||||
– see also obstruction; occlusion; stricture |
– anatomy 477 |
|
|
|
|
|
– – cystic |
180, 192–194 |
|||||||||
stents |
|
|
|
– circumscribed changes |
489–494 |
|
– parathyroid 494, 500 |
||||||||||
– biliary 140 |
|
|
|
– diffuse changes 479–489 |
|
|
– portovenous involvement 51 |
||||||||||
– bilioduodenal 138 |
|
– enlargement 479–483 |
|
|
|
– pulmonary 544–546 |
|
||||||||||
– endovascular |
24 |
|
– functions 477 |
|
|
|
|
|
– splenic |
206, 215–217, 225 |
|||||||
– – carotid 18 |
|
|
– regressive changes |
500, 501, 503 |
|
– staging of see staging |
|
||||||||||
– pancreatic duct 190 |
|
– topography |
478 |
|
|
|
|
– testicular |
239, 432, 433 |
||||||||
sternum 511 |
|
|
|
thyroid peroxidase (TPO), autoantibodies |
480, |
– thyroid |
491–494, 495–498, 499, 500, 501, |
||||||||||
– fractures 513 |
|
481, 487 |
|
|
|
|
|
|
502, 503 |
|
|
|
|||||
– metastases |
514 |
|
thyroid-stimulating hormone (TSH), serum le- |
– urinary tract |
|
|
|||||||||||
steroid cell tumor, ovarian 471 |
|
vels 492 |
|
|
|
|
|
|
– – bladder |
404–405, 407, 411, 412 |
|||||||
stomach (gastric...) 266–274, 316–317 |
|
thyroid-stimulating hormone (TSH) receptor, |
– – renal |
334, 352–356, 357, 359, 364 |
|||||||||||||
– anatomy and tomography 261 |
|
autoantibodies |
480, 481, 484, 487 |
|
– – ureter, causing obstruction 390 |
||||||||||||
– cancer 267, 270 |
|
thyroiditis 480, 483–485, 487, 488–489, 505 |
– uterine |
445, 446, 448–450, 450, 456–458, |
|||||||||||||
– – metastatic |
113, 122, 301 |
|
– chronic, with transient hyperthyroidism 487 |
473 |
|
|
|
|
|
||||||||
– emptying, dysfunction 272 |
|
– de Quervain see de Quervain thyroiditis |
|
– see also specific types |
|
||||||||||||
– gut signature |
264 |
|
– drug-induced |
485, 488 |
|
|
tumorlike ovarian lesions 469 |
||||||||||
– morphology |
262 |
|
– Hashimoto see Hashimoto thyroiditis |
|
tunica adventitia/intima/media see adventitia; |
||||||||||||
– outlet obstruction 272, 317 |
|
– interferon-induced |
489 |
|
|
intima; media |
|
|
|||||||||
– peristalsis 263 |
|
– invasive sclerosing |
483 |
|
|
tunica albuginea, fibroma 436 |
|||||||||||
stones see calculi |
|
– postpartum 487 |
|
|
|
|
|
|
|
|
|
|
|||||
stricture, ureteral 390 |
|
– silent/sporadic |
488 |
|
|
|
|
U |
|
|
|
|
|
||||
– see also obstruction; occlusion; stenosis |
thyroxine (T4) 477 |
|
|
|
|
|
|
|
|
|
|||||||
stromal tumors |
|
TNM staging of tumors |
|
|
|
|
|
|
|
|
|
||||||
– gastrointestinal (GIST) 266, 275 |
|
– bladder carcinoma |
412 |
|
|
ulceration |
|
|
|
||||||||
– sex cord 469, 471 |
|
– with lymph node metastases |
241, 257 |
|
– duodenal, perforated |
305, 306, 308, 312 |
|||||||||||
struma ovarii |
472 |
|
– ovarian cancer |
466, 468 |
|
|
– gastric |
269 |
|
|
|||||||
strumectomy |
486 |
|
– prostatic carcinoma |
419 |
|
|
ulcerative colitis |
285 |
|
||||||||
subcapsular lesions (of spleen) |
|
– uterine corpus |
456 |
|
|
|
|
umbilical hernia |
281 |
|
|||||||
– hemorrhage |
219 |
|
torsion |
|
|
|
|
|
|
|
umbilical vein recanalization 45 |
||||||
– rupture 222 |
|
|
– testicular 430 |
|
|
|
|
|
undifferentiated/anaplastic tumors (incl. carci- |
||||||||
superficial venous thrombosis 34 |
|
– uterine pedunculated tumor |
473 |
|
nomas) |
|
|
|
|
||||||||
suppurative lesions see pyogenic lesions |
|
transabdominal ultrasound, female genital |
– kidney |
352 |
|
|
|||||||||||
supraclavicular structures 244 |
|
tract 441 |
|
|
|
|
|
|
– liver |
134, 195 |
|
|
|||||
suprarenal glands see adrenal glands |
|
transitional cell carcinoma of urinary tract |
– pancreas 183 |
|
|
||||||||||||
surgery, status after see postoperative status |
(urothelial carcinoma) |
354, 355, 394 |
|
– thyroid |
496, 504 |
|
|||||||||||
surgical capsule (hyperplastic prostate) |
426 |
transitional cell tumor of ovaries 470 |
|
ureter |
394–398 |
|
|
||||||||||
suture complications with bypass grafts |
27 |
transplantation and grafting (allogeneic) |
|
– bifid |
384 |
|
|
|
|||||||||
|
|
|
|
– bone marrow, graft-versus-host disease |
211 |
– course |
382 |
|
|
||||||||
T |
|
|
|
– renal 364 |
|
|
|
|
|
|
– duplex |
384 |
|
|
|||
|
|
|
– – rejection |
334 |
|
|
|
|
– ectopic |
391, 424 |
|
||||||
|
|
|
|
transudates |
|
|
|
|
|
|
– function and its assessment 389–390 |
||||||
Takayasu arteritis 15, 21 |
|
– peritoneal |
300 |
|
|
|
|
– jets 408 |
|
|
|
||||||
tampon 443 |
|
|
|
– pleural |
524, 525 |
|
|
|
|
– length and diameter |
381 |
||||||
tamponade, bladder 403 |
|
transurethral resection (TUR) of prostate |
422, |
– mass |
394–398 |
|
|
||||||||||
temporal (giant-cell) arteritis 15, 21 |
|
424, 425 |
|
|
|
|
|
|
– – stones 390, 397 |
|
|||||||
teratoma, ovarian 472 |
|
trauma see injuries |
|
|
|
|
– – tumor obstruction |
390 |
|||||||||
|
|
|
|
tri-iodothyronine (T3) |
477 |
|
|
|
|
|
|
|
|
564
– stricture |
390 |
|
|
varices and varicosities |
ventricular failure, right-sided (=right-sided |
||||||
– see also megaureter |
|
|
– esophageal |
45 |
heart failure) 301, 312, 337 |
||||||
ureterocele |
390, 407, 413 |
|
– gallbladder |
156 |
vesicorenal reflux 391 |
||||||
ureteropelvic junction |
382 |
|
– gastric |
268 |
vesicoureteral junction see ureterovesical |
||||||
– obstruction 385 |
|
|
– mesenteric |
253 |
junction |
|
|
||||
– – stone |
388, 390 |
|
|
– pampiniform venous plexus (= varicocele) |
vesicoureteral reflux |
391 |
|||||
ureterovesical junction obstruction |
385 |
436 |
|
|
vesiculitis (seminal) |
427, 428 |
|||||
– stone |
388 |
|
|
vas deferens |
429 |
viral hepatitis 78, 143 |
|||||
urethra, male 417 |
|
|
vascular malformations and anomalies |
von Meyenburg hamartoma 66, 112 |
|||||||
– see also transurethral resection |
|
– biliary obstruction due to 135 |
|
|
|
||||||
urinary tract 379–414 |
|
|
– hepatic |
95 |
|
W |
|
|
|||
– anatomy |
381 |
|
|
– – metastases 97 |
|
|
|||||
– catheter |
406 |
|
|
– pancreatic |
169–170 |
|
|
|
|||
– malformations see congenital anomalies and |
– renal 328–329 |
Waldenström macroglobulinemia 342 |
|||||||||
variants |
|
|
|
– – scars |
360 |
wall |
|
|
|||
– obstruction 385, 390, 392 |
|
– see also arteriovenous malformations; dila- |
– abdominal |
309 |
|
||||||
– stones see urolithiasis |
|
tations |
|
|
– arterial/aortic, thickening 19–22 |
||||||
– topography 382 |
|
|
vascularity of gastrointestinal tract and hyper- |
– bile duct, thickening 130–131, 142 |
|||||||
– urothelial carcinoma |
354, 355, 394 |
vascularization (of lesions/masses) 262, 263 |
– bladder 410–414 |
|
|||||||
urine |
|
|
|
|
|
vascularization and hypervascularization (of |
– – indentations 402, 408 |
||||
– flow/transport stasis |
388 |
|
lesions/masses) |
– chest see chest wall |
|||||||
– – chronic |
389–390 |
|
|
– liver 87, 102 |
– gallbladder see gallbladder |
||||||
– outflow obstruction |
390 |
|
– lymph nodes 236–238 |
– gastrointestinal tract 270–271 |
|||||||
– – acute |
332 |
|
|
– pancreatic cancer 183, 184 |
– – intestine |
274–287 |
|||||
– reflux 391–392 |
|
|
– splenic |
224, 226 |
– – layering |
262, 263 |
|||||
– residual 400 |
|
|
vasculature (blood vessels/supply) 1–53 |
– – thickness and thickening 262, 263 |
|||||||
– retention |
398–399 |
|
|
– biliary tree-adjacent, cholestasis and 142 |
– peritoneal |
312–316 |
|||||
– – acute |
332 |
|
|
– hepatic, anechoic masses 95 |
– vaginal, cyst 443 |
|
|||||
urinoma |
302, 349 |
|
|
– malignancy involving see malignant tumors |
white thrombus 21, 23 |
||||||
urolithiasis (urinary stones/calculi) |
388, |
– pancreatic |
181 |
WHO see World Health Organization |
|||||||
395–396 |
|
|
|
– pulmonary see pulmonary vessels |
Wilms tumor 354 |
|
|||||
– bladder |
409 |
|
|
– renal 321 |
|
Wirsung’s duct see pancreatic duct |
|||||
– colic |
388 |
|
|
– splenic |
203, 205–206 |
World Health Organization (WHO) |
|||||
– renal |
362, 392 |
|
|
– – calcification 229 |
– atherosclerosis definition 19 |
||||||
– renal pelvis and calices 396–397 |
|
– thyroid |
477, 478, 491 |
– ovarian cancer staging 466 |
|||||||
– – staghorn calculus |
363, 392, 396 |
– uterine |
444 |
– renal (incl. renal pelvis) tumor classification |
|||||||
– ureter 390, 397 |
|
|
– see also arteries; veins and specific vessels |
352, 394 |
|
|
|||||
urothelial carcinoma 354, 355, 394 |
|
vasculitis |
15, 21 |
– thyroid tumor classification 496 |
|||||||
uterine artery 444 |
|
|
veins 29–38 |
|
|
|
|
||||
uterus |
444–458 |
|
|
– compression or infiltration 37–38 |
X |
|
|
||||
– anatomy |
444–445 |
|
|
– dilatation 31–33 |
|
|
|||||
– intracavitary changes 451–453 |
|
– – inferior vena cava 31–33 |
|
|
|
||||||
– morphology 445 |
|
|
– – renal vein 349 |
xanthogranulomatous cholecystitis 152 |
|||||||
– myometrial changes |
446–450 |
|
– intraluminal mass see intraluminal lesions |
xanthomatous pyelonephritis 259, 357 |
|||||||
– neck see cervix |
|
|
– varices see varices and varicosities |
|
|
|
|||||
– size and shape abnormalities 446–447 |
– see also specific veins |
Y |
|
|
|||||||
– tumors |
445, 446, 448–450, 450, 456–458, |
vena cava, inferior 29–38 |
|
|
|||||||
473 |
|
|
|
|
|
– anatomy and topography 4 |
yolk sac tumor 472 |
|
|||
utricular cyst 424 |
|
|
– anomalies |
29–31 |
|
||||||
|
|
|
|
|
|
– dilatation 31–33 |
|
|
|
||
V |
|
|
|
|
|
– intraluminal mass 34–36 |
|
|
|
||
|
|
|
|
|
– see also aortointercaval lymph nodes; para- |
|
|
|
|||
|
|
|
|
|
|
caval lymph nodes |
|
|
|
||
vagina |
442–444 |
|
|
veno-occlusive disease 37, 47 |
|
|
|
||||
valves, venous 36 |
|
|
ventral (pancreatic) anlage 185, 187 |
|
|
|
Index
565